<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2017.00619</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Morphological and Functional Inner and Outer Retinal Layer Abnormalities in Eyes with Permanent Temporal Hemianopia from Chiasmal Compression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ara&#x000FA;jo</surname> <given-names>Rafael B. de</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/480151"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Oyamada</surname> <given-names>Maria K.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/496366"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zacharias</surname> <given-names>Leandro C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/496411"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cunha</surname> <given-names>Leonardo P.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/483989"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Preti</surname> <given-names>Rony C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/496328"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Monteiro</surname> <given-names>M&#x000E1;rio L. R.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/475709"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Investigation in Ophthalmology (LIM 33), Division of Ophthalmology, University of S&#x000E3;o Paulo Medical School</institution>, <addr-line>S&#x000E3;o Paulo</addr-line>, <country>Brazil</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Ophtalmology, School of Medicine, Federal University of Juiz de Fora</institution>, <addr-line>Juiz de Fora</addr-line>, <country>Brazil</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Andrzej Grzybowski, University of Warmia and Mazury in Olsztyn, Poland</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Enrico Borrelli, University of California, Los Angeles, United States; Andr&#x000E9;s Cruz-Herranz, University of California, San Francisco, United States</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: M&#x000E1;rio L. R. Monteiro, <email>mlrmonteiro&#x00040;terra.com.br</email></corresp>
<fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Neuro-Ophthalmology, a section of the journal Frontiers in Neurology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>619</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>09</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Ara&#x000FA;jo, Oyamada, Zacharias, Cunha, Preti and Monteiro.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Ara&#x000FA;jo, Oyamada, Zacharias, Cunha, Preti and Monteiro</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract abstract-type="executive-summary">
<sec id="ST1">
<title>Purpose</title>
<p>The aims of this study are to compare optical coherence tomography (OCT)-measured macular retinal layers in eyes with permanent temporal hemianopia from chiasmal compression and control eyes; to compare regular and slow-flash multifocal electroretinography (mfERG) in patients and controls; and to assess the correlation between OCT, mfERG, and central visual field (SAP) data.</p>
</sec>
<sec id="ST2">
<title>Methods</title>
<p>Forty-three eyes of 30 patients with permanent temporal hemianopia due to pituitary tumors who were previously submitted to chiasm decompression and 37 healthy eyes of 19 controls were submitted to macular spectral domain OCT, mfERG, and 10-2 SAP testing. After segmentation, the thickness of the macular retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer, and photoreceptor layer (PRL) was measured. Amplitudes and oscillatory potentials (OPs) were measured on regular and slow-flash mfERG, respectively, and expressed as the mean values per quadrant and hemifield.</p>
</sec>
<sec id="ST3">
<title>Results</title>
<p>RNFL, GCL, and IPL thickness measurements were significantly reduced in all quadrants, whereas INL, OPL, and PRL thicknesses were significantly increased in the nasal quadrants in patients compared to those in controls. Significant correlations between OCT and 10-2 SAP measurements were positive for the RNFL, GCL, and IPL and negative for the INL, OPL, and PRL. OPs and mfERG N1 amplitudes were significantly reduced in the nasal hemiretina of patients. Significant correlations were found between OP and mfERG amplitudes for inner and outer nasal hemiretina OCT measurements, respectively.</p>
</sec>
<sec id="ST4">
<title>Conclusion</title>
<p>Patients with permanent temporal hemianopia from previously treated chiasmal compression demonstrated significant thinning of the RNFL, GCL, IPL, and thickening of the INL, OPL, and PRL associated with reduced OP and mfERG N1 amplitudes, suggesting that axonal injury to the inner retina leads to secondary damage to the outer retina in this condition.</p>
</sec>
</abstract>
<kwd-group>
<kwd>optical coherence tomography</kwd>
<kwd>oscillatory potentials</kwd>
<kwd>multifocal electroretinography</kwd>
<kwd>standard automated perimetry</kwd>
<kwd>chiasmal compression</kwd>
<kwd>temporal hemianopia</kwd>
</kwd-group>
<contract-num rid="cn01">2013/26585-5</contract-num>
<contract-num rid="cn02">307393/2014-3</contract-num>
<contract-sponsor id="cn01">Funda&#x000E7;&#x000E3;o de Amparo &#x000E0; Pesquisa do Estado de S&#x000E3;o Paulo<named-content content-type="fundref-id">10.13039/501100001807</named-content></contract-sponsor>
<contract-sponsor id="cn02">Conselho Nacional de Desenvolvimento Cient&#x000ED;fico e Tecnol&#x000F3;gico<named-content content-type="fundref-id">10.13039/501100003593</named-content></contract-sponsor>
<contract-sponsor id="cn03">Coordena&#x000E7;&#x000E3;o de Aperfei&#x000E7;oamento de Pessoal de N&#x000ED;vel Superior<named-content content-type="fundref-id">10.13039/501100002322</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="72"/>
<page-count count="12"/>
<word-count count="8365"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>Optical coherence tomography (OCT) has become a valuable tool not only in the workup of patients with retinal diseases but also in the quantification of retinal neural loss in patients with optic pathway diseases. Reduced thickness of the OCT-measured peripapillary retinal nerve fiber layer (RNFL), macular RNFL, and ganglion cell layer (GCL) thickness are important signs in a number of optic neuropathies, including glaucoma (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B3">3</xref>), optic neuritis from multiple sclerosis (MS) or neuromyelitis optica (NMO) (<xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>), and hereditary and compressive optic neuropathies (<xref ref-type="bibr" rid="B7">7</xref>&#x02013;<xref ref-type="bibr" rid="B13">13</xref>). Therefore, the quantification of peripapillary RNFL and inner macular layers with high-resolution OCT became a common procedure to diagnose and monitor such conditions.</p>
<p>However, more recently, the widespread use of OCT in optic nerve diseases has revealed retinal abnormalities in layers other than the RNFL and the GCL. Increased thickness and microcystic abnormalities in the inner nuclear layer (INL) were first noticed in MS and NMO (<xref ref-type="bibr" rid="B14">14</xref>&#x02013;<xref ref-type="bibr" rid="B18">18</xref>) and later in other optic neuropathies (<xref ref-type="bibr" rid="B19">19</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>), in chiasmal compression (<xref ref-type="bibr" rid="B22">22</xref>), and in optic tract lesion (<xref ref-type="bibr" rid="B23">23</xref>). Although the mechanism has not been clearly established, the presence of INL microcysts in areas of GCL loss points to either mechanical stretching of the retina in the area or retrograde trans-synaptic cell degeneration (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B22">22</xref>). The observation of secondary INL abnormalities in eyes with anterior visual pathway lesions increases the likelihood of finding abnormalities in the outer retinal layers as well. These layers can now be measured separately with spectral domain OCT (SD-OCT) technology.</p>
<p>Outer retinal layer function may be evaluated with full-field electroretinography (ffERG). The main components of regular ERG data reflect cone and rod responses, while the activity of retinal cells with nuclei located in the INL may be assessed by analyzing the oscillatory potentials (OPs), which are thought to arise preferentially from amacrine cell activity and its interaction with bipolar and ganglion cells (<xref ref-type="bibr" rid="B24">24</xref>&#x02013;<xref ref-type="bibr" rid="B29">29</xref>). However, ffERG is a global retinal response and therefore not ideal for evaluating possible localized consequences of retinal axonal loss in optic nerve diseases. Multifocal electroretinography (mfERG), on the other hand, reflects a cone-driven response, predominantly generated by bipolar cell activity from different areas in the central retina (<xref ref-type="bibr" rid="B30">30</xref>). In its regular protocol, mfERG is a standard test for the evaluation of outer retinal layer function, but it has been suggested that nonstandard modes of mfERG stimulation and analysis can enhance the contributions of amacrine and bipolar cells in the INL (<xref ref-type="bibr" rid="B25">25</xref>). In that regard, modified slow-flash mfERG (SF-mfERG) successfully enhanced OPs, believed to represent intermediate retinal layer activity, in different regions of the macula (<xref ref-type="bibr" rid="B31">31</xref>). Previous studies have evaluated inner and intermediate retinal layer function using multifocal OPs (mfOPs) in normal aged persons (<xref ref-type="bibr" rid="B30">30</xref>) and patients with retinal diseases (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B32">32</xref>&#x02013;<xref ref-type="bibr" rid="B36">36</xref>) and glaucoma (<xref ref-type="bibr" rid="B37">37</xref>). However, no previous study has specifically addressed the mfERG response in patients with chiasmal disease.</p>
<p>While the inner retinal layers are known to be affected in optic nerve diseases, it remains unclear whether the structures of the outer retinal layer, including the photoreceptor layer (PRL), are also involved. Some histological (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>) and electroretinographic (<xref ref-type="bibr" rid="B40">40</xref>) studies in glaucoma suggest that the PRL is affected in the disease, but other studies have failed to confirm that (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). In MS patients, Saidha et al. (<xref ref-type="bibr" rid="B43">43</xref>) found indications of primary involvement of the outer retinal layer in a subset of the disease, and recent studies indicate that outer retinal changes may be secondary to optic neuritis in that condition (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). However, the effect of primary anterior visual pathway disease on the outer retina is still not well understood. The subject is important, not only from the pathophysiological point of view but also because it helps avoid diagnostic confusion between optic nerve and retinal diseases. Patients with band atrophy (BA) of the optic nerve (<xref ref-type="bibr" rid="B46">46</xref>&#x02013;<xref ref-type="bibr" rid="B48">48</xref>) resulting from middle chiasmal compression provide a good model for the investigation of retinal abnormalities secondary to anterior visual pathway disease. Typical cases have temporal hemianopia with normal nasal visual field (VF) (<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>). Because such patients are affected at the chiasmal level, have no primary ocular diseases and present eyes with temporal hemianopia with normal or near-normal nasal hemifield (with a clear distinction between nasal and temporal hemiretinal involvements), they provide valuable information on possible secondary retinal layer involvement (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B49">49</xref>). However, to our knowledge, no previous study has used OCT or mfERG to evaluate the segmented outer retinal layers of patients with VF loss from chiasmal compression.</p>
<p>Therefore, the purposes of the present study are to compare segmented inner and outer retinal layers using high-resolution SD-OCT and assess their function using SF-mfERG and regular mfERG recordings in eyes with temporal hemianopia and controls, as well as to determine the relationship between such measurements. We also evaluated the relationship between SD-OCT findings and central VF data from standard automated perimetry (SAP, 10-2-testing strategy) in the same set of patients.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>Subjects</title>
<p>Forty-three eyes of 30 patients with temporal hemianopia from previous chiasmal compression and 37 eyes of 19 healthy controls were included in this observational, prospective, cross-sectional study. All patients had received treatment for suprasellar lesions and had stable visual acuity and VF defects for at least 6&#x02009;months prior to the study. Approval from the Institutional Ethics Committee was obtained, and all subjects filled informed consent. The study designers followed the principles of the Declaration of Helsinki.</p>
<p>To be eligible, patients were required to (i) be older than 18&#x02009;years; (ii) have radiologic evidence of a previous suprasellar tumor compressing the chiasm, followed by optic pathway decompression at least 6&#x02009;months prior to study entry; and (iii) have at least one eye with complete or partial temporal hemianopia and a nasal hemifield within normal limits. An abnormal temporal hemifield was defined on 24-2 VF examination as follows: a cluster of at least three non-edge locations worse than a <italic>P</italic> value of 5%, with at least one worse than a <italic>P</italic> level of 1% on the pattern deviation plot of the temporal hemifield; best-corrected visual acuity of 20/30 or better; spherical equivalent of &#x000B1;4.00 diopters and IOP&#x02009;&#x0003C;&#x02009;22&#x02009;mmHg. Patients with a history of intraocular diseases, diabetes, clinical signs of glaucoma, or other optic neuropathies were excluded.</p>
<p>The control group consisted of healthy subjects recruited among hospital personnel. All individuals had no abnormalities in the ophthalmic examination or the 24-2 SAP. Normal VF was defined as a pattern standard deviation within the 95% confidence limits and a Glaucoma Hemifield Test result within normal limits.</p>
</sec>
<sec id="S2-2">
<title>VF Testing</title>
<p>All subjects were submitted to SAP using the Swedish Interactive Thresholding Algorithm (SITA) Standard 24-2 test (Humphrey Field Analyzer, Carl Zeiss Meditec) with a Goldmann III size stimulus on a 31.5-apostilb background for inclusion purposes. Eligible eyes underwent SITA 10-2 testing, and only reliable VFs were included (fixation loss &#x0003C;20%, false-positive rate &#x0003C;15%, and false-negative rate &#x0003C;30%). The primary analysis consisted of averaging VF deviation from normal values on the total deviation plot in the nasal and temporal hemifields and in the superonasal (SN), inferonasal (IN), superotemporal (ST), and inferotemporal (IT) quadrants. Sectoral mean deviation (MD) and mean sensitivity values were calculated. At each test point, sensitivity values were measured in decibel by averaging the values of the total deviation plot for points in each quadrant and hemifield. Also, for the purpose of calculation, the deviation from normal at each test location was converted from decibel to unlogged 1/Lambert (1/L) units using the formula: 1/L&#x02009;&#x0003D;&#x02009;10<sup>dB/10</sup>.</p>
</sec>
<sec id="S2-3">
<title>OCT Analysis and Segmentation</title>
<p>Within 2&#x02009;weeks of VF testing, the subjects were submitted to SD-OCT scanning (Spectralis, Heidelberg Engineering, Heidelberg, Germany) of the macular area following pupil dilation with 1% tropicamide. All participants were examined using the posterior pole protocol of the Spectralis Nsite Axonal Analytics software. A quality index of at least 20 was required for all images. The images were acquired using the automated eye alignment eye-tracking software (TruTrack; Heidelberg Engineering) and corrected with the Fovea-to-Disc Alignment system to obtain macular volumetric retinal scans comprising 61 single vertical lines of 16 frames each, covering a cuboid area of 30&#x000B0;&#x02009;&#x000D7;&#x02009;25&#x000B0; volume scan (9.2&#x02009;mm&#x02009;&#x000D7;&#x02009;7.6&#x02009;mm) centered on the fovea, to increase the accuracy of horizontal raphe measurements, and to minimize the variation in head orientation. A central 6&#x02009;mm&#x02009;&#x000D7;&#x02009;6&#x02009;mm square of the scanned area was used for analysis (Figure <xref ref-type="fig" rid="F1">1</xref>). The software scores the quality of the signal strength of the images on a scale from poor (0&#x02009;dB) to excellent (40&#x02009;dB). All images were reviewed with regard to subjective and objective quality (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Criteria for acceptable Spectralis<sup>&#x000AE;</sup> fundus images included the following: absence of large eye movements (defined as an abrupt shift completely disconnecting a large retinal vessel), consistent signal intensity across the scan, and absence of black bands (caused by blinking) throughout the examination.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Demarcation of the area in the macula scanned by spectral domain optical coherence tomography. The enhanced squares represent the area used for analysis, divided into four quadrants and two hemifields (white lines). Note the inclination of the scans due to fovea-disk correction. Peripheral squares were excluded from calculations.</p></caption>
<graphic xlink:href="fneur-08-00619-g001.tif"/>
</fig>
<p>Seven retinal layers were identified by automatic segmentation performed by the Spectralis<sup>&#x000AE;</sup> software, with manual correction when needed. After segmentation, we measured the thickness of the following layers between the outer limiting membrane and Bruch&#x02019;s membrane: the RNFL, the GCL, the inner plexiform layer (IPL), the INL, the outer plexiform layer (OPL), the outer nuclear layer (ONL), and the PRL (<xref ref-type="bibr" rid="B52">52</xref>) (Figure <xref ref-type="fig" rid="F2">2</xref>). The average thickness in macular quadrants and hemifields was calculated for each layer.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>A spectral domain optical coherence tomography scan of the fovea of a normal subject showing the retinal segments measured in this study. The colored lines indicate the boundaries between the layers. RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer.</p></caption>
<graphic xlink:href="fneur-08-00619-g002.tif"/>
</fig>
</sec>
<sec id="S2-4">
<title>Electroretinography</title>
<p>Multifocal electroretinography was recorded using the RETiscan System (Roland Consult, Wiesbaden, Germany) following the International Society for Clinical Electrophysiology of Vision (ISCEV) guidelines (<xref ref-type="bibr" rid="B53">53</xref>). The tests were performed monocularly, after anesthetizing the cornea with one drop of proxymetacaine 0.5%, using ERG-Jet contact lens electrodes (Fabrinal SA, La Chaux de Fonds, Switzerland). Gold-cup reference and surface electrodes were placed on the subject&#x02019;s forehead and temple, respectively. The pupils were previously dilated with 1% tropicamide, and the subject was light adapted for 10&#x02009;min before the examination. The stimulus array consisted of 61 hexagons scaled with a 4.0 distortion and eccentricity factor randomly displayed on a CRT monitor at a distance of 26&#x02009;cm and directed at the central 30&#x000B0; of the retina. The luminance of the stimuli was modulated between black (0&#x02009;cd/m<sup>2</sup>) and white (200&#x02009;cd/m<sup>2</sup>), according to a modified pseudorandom m-sequence. The recordings were amplified and automatically bandpass filtered (filter range 10&#x02013;100&#x02009;Hz). The mfERG N1 and P1 amplitudes were measured according to ISCEV guidelines (<xref ref-type="bibr" rid="B53">53</xref>).</p>
<p>Multifocal OP responses were acquired by SF-mfERG stimulation, with the same 61-hexagon array and the same display used for mfERG recordings. Each hexagon was temporally modulated between black (0&#x02009;cd/m<sup>2</sup>) and white (200&#x02009;cd/m<sup>2</sup>) in a pseudorandom binary m-sequence comprising 2<sup>13</sup>-1 steps. The display luminance around the hexagons was approximately 100&#x02009;cd/m<sup>2</sup>. For this acquisition protocol, the sequence was slowed by inserting three dark frames making each step four frames long (53.3&#x02009;ms). Each recording session took approximately 13&#x02009;min per eye, with 98&#x02009;s per stimulation cycle. Retinal signals were bandpass filtered between 100 and 300&#x02009;Hz and amplified (range, 100&#x02009;&#x000B5;V) (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>The subjects were asked to fix their gaze on the red cross at the center of the stimulus screen. Recordings with artifacts from head movements, blinking or contact lens uncoupling were discarded and repeated. The amplitudes of the three major waveforms (P1, P2, and P3) of the SF-mfERG recordings were measured and summed to determine the total OP amplitude (Figure <xref ref-type="fig" rid="F3">3</xref>). The responses were measured using scaled density regional averages in nV/deg<sup>2</sup> to reflect the correct angular size for each hexagon stimulating the retina. Disregarding the outermost line of stimulus, SF-mfERG Ops, and conventional mfERG N1 and P1 responses were evaluated for a customized quadrantic pattern (excluding the hexagons in the central vertical and horizontal lines) and for the nasal and temporal hemiretinas (excluding the hexagons in the central vertical line) (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Spatially summed waveforms of regular and slow-flash mfERG of a 34-year-old healthy control. OP amplitude (upper graph) is the difference in nanovolts between a peak and the preceding trough. The final OP amplitude is the sum of the three amplitudes. In the mfERG waveform (lower graph), the N1 amplitude is the difference in nanovolts between the baseline and the first trough; the P1 amplitude is the difference in nanovolts between the first trough and the first peak.</p></caption>
<graphic xlink:href="fneur-08-00619-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Representation of the 61-hexagon array of retinal stimulation used in both regular and slow-flash mfERG. Note the exclusion of peripheral and midline hexagons from the analysis. <bold>(A)</bold> Quadrantic analysis. <bold>(B)</bold> Hemiretinal analysis.</p></caption>
<graphic xlink:href="fneur-08-00619-g004.tif"/>
</fig>
</sec>
<sec id="S2-5">
<title>Statistical Analysis</title>
<p>The statistical analysis of the computed data was performed with IBM SPSS Statistics v. 23.0. The Kolmogorov&#x02013;Smirnov test was used to confirm the normality assumption. BA patients and normal controls were compared with regard to OCT quadrantic and hemiretinal macular thickness, mean OP amplitudes, and mfERG amplitudes using generalized estimating equations. Receiver operating characteristic (<xref ref-type="bibr" rid="B52">52</xref>) curves were used to assess the discrimination ability of each parameter. Correlations between either SD-OCT or electrophysiology measurements and mean SAP sensitivity were verified with either Spearman&#x02019;s ranked correlation coefficients (&#x003C1;) for SAP values in decibels (<xref ref-type="bibr" rid="B40">40</xref>) or Pearson&#x02019;s correlation coefficients (<italic>r</italic>) for SAP values in 1/L units. The level of statistical significance was set at 5% (<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05).</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<p>A total of 43 eyes with BA and 37 healthy eyes were studied. All patients had pituitary adenoma. The mean age&#x02009;&#x000B1;&#x02009;SD was 53.7&#x02009;&#x000B1;&#x02009;13.3&#x02009;years for the patients and 49.7&#x02009;&#x000B1;&#x02009;12.9&#x02009;years for the controls (<italic>P</italic>&#x02009;&#x0003D;&#x02009;0.182, Student&#x02019;s <italic>t</italic>-test). One subject from the control group had one eye excluded due to a macular scar. On 24-2 SAP testing, 22 eyes presented complete temporal hemianopia, 11 had a defect affecting approximately one quadrant, and 10 had a defect involving less than one quadrant. The mean&#x02009;&#x000B1;&#x02009;SD of 10-2 SAP MD was &#x02212;10.38&#x02009;&#x000B1;&#x02009;6.8&#x02009;dB in the BA group and &#x02212;1.62&#x02009;&#x000B1;&#x02009;1.2&#x02009;dB in the control group. In BA eyes, the temporal and nasal mean defect was &#x02212;18.0&#x02009;&#x000B1;&#x02009;1.2 and &#x02212;2.6&#x02009;&#x000B1;&#x02009;1.1, respectively. The corresponding values for normal eyes were &#x02212;1.2&#x02009;&#x000B1;&#x02009;1.0 and &#x02212;1.1&#x02009;&#x000B1;&#x02009;0.9. The mean defect of the VF quadrants on the 10-2 test was &#x02212;17.9&#x02009;&#x000B1;&#x02009;11.3 (ST), &#x02212;2.2&#x02009;&#x000B1;&#x02009;3.5 (SN), &#x02212;18.1&#x02009;&#x000B1;&#x02009;13.1 (IT), and &#x02212;2.9&#x02009;&#x000B1;&#x02009;3.3 (IN). The corresponding values for controls were &#x02212;1.2&#x02009;&#x000B1;&#x02009;1.2, &#x02212;1.1&#x02009;&#x000B1;&#x02009;1.1, &#x02212;1.1&#x02009;&#x000B1;&#x02009;0.9, and &#x02212;1.2&#x02009;&#x000B1;&#x02009;0.8. All VF sensitivity parameters in both hemifields were significantly smaller in BA patients than in controls.</p>
<p>The macular thickness parameters for each retinal layer and each quadrant are presented in Table <xref ref-type="table" rid="T1">1</xref>, and the pseudocolor thickness maps of each segmented layer from a typical BA patient and a normal control are shown in Figure <xref ref-type="fig" rid="F5">5</xref>, with their respective 10-VF total deviation plot and electrophysiological waveforms. RNFL, GCL, and IPL thickness measurements in all four macular quadrants were significantly smaller in eyes with BA than in control eyes. The largest differences were found in the nasal quadrants. These measurements also had the best area under the receiver operating characteristic curve for distinguishing eyes with BA from controls. On the other hand, in the SN and IN quadrants, INL, OPL, and PRL thickness was significantly greater in BA eyes than in control eyes, while no significant difference was found for the temporal quadrants. Moreover, no significant difference was found for ONL measurements, regardless of the quadrant (Table <xref ref-type="table" rid="T1">1</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Mean values (&#x000B1;SD) of the segmented macular layers thicknesses (in micrometers) by quadrants with AUC.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Parameter</th>
<th valign="top" align="center">Band atrophy</th>
<th valign="top" align="center">Controls</th>
<th valign="top" align="center"><italic>P</italic> value<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></th>
<th valign="top" align="center">AUC</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="5"><bold>Superonasal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">RNFL</td>
<td align="center" valign="top">32.2&#x02009;&#x000B1;&#x02009;9.5</td>
<td align="center" valign="top">50.5&#x02009;&#x000B1;&#x02009;8.0</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.933</td>
</tr>
<tr>
<td align="left" valign="top">GCL</td>
<td align="center" valign="top">23.5&#x02009;&#x000B1;&#x02009;3.8</td>
<td align="center" valign="top">34.5&#x02009;&#x000B1;&#x02009;2.3</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.982</td>
</tr>
<tr>
<td align="left" valign="top">IPL</td>
<td align="center" valign="top">19.8&#x02009;&#x000B1;&#x02009;2.9</td>
<td align="center" valign="top">27.6&#x02009;&#x000B1;&#x02009;1.7</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.977</td>
</tr>
<tr>
<td align="left" valign="top">INL</td>
<td align="center" valign="top">34.8&#x02009;&#x000B1;&#x02009;3.2</td>
<td align="center" valign="top">32.4&#x02009;&#x000B1;&#x02009;5.2</td>
<td align="center" valign="top"><bold>0.015</bold></td>
<td align="center" valign="top">0.778</td>
</tr>
<tr>
<td align="left" valign="top">OPL</td>
<td align="center" valign="top">27.9&#x02009;&#x000B1;&#x02009;3.3</td>
<td align="center" valign="top">26.4&#x02009;&#x000B1;&#x02009;2.0</td>
<td align="center" valign="top"><bold>0.009</bold></td>
<td align="center" valign="top">0.624</td>
</tr>
<tr>
<td align="left" valign="top">ONL</td>
<td align="center" valign="top">60.5&#x02009;&#x000B1;&#x02009;5.4</td>
<td align="center" valign="top">59.3&#x02009;&#x000B1;&#x02009;8.7</td>
<td align="center" valign="top">0.528</td>
<td align="center" valign="top">0.494</td>
</tr>
<tr>
<td align="left" valign="top">PRL</td>
<td align="center" valign="top">81.4&#x02009;&#x000B1;&#x02009;3.0</td>
<td align="center" valign="top">79.5&#x02009;&#x000B1;&#x02009;2.3</td>
<td align="center" valign="top"><bold>0.007</bold></td>
<td align="center" valign="top">0.692</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Inferonasal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">RNFL</td>
<td align="center" valign="top">38.8&#x02009;&#x000B1;&#x02009;12.2</td>
<td align="center" valign="top">57.8&#x02009;&#x000B1;&#x02009;7.6</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.897</td>
</tr>
<tr>
<td align="left" valign="top">GCL</td>
<td align="center" valign="top">22.6&#x02009;&#x000B1;&#x02009;3.4</td>
<td align="center" valign="top">33.7&#x02009;&#x000B1;&#x02009;2.3</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.988</td>
</tr>
<tr>
<td align="left" valign="top">IPL</td>
<td align="center" valign="top">18.8&#x02009;&#x000B1;&#x02009;2.5</td>
<td align="center" valign="top">26.7&#x02009;&#x000B1;&#x02009;1.9</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.987</td>
</tr>
<tr>
<td align="left" valign="top">INL</td>
<td align="center" valign="top">34.3&#x02009;&#x000B1;&#x02009;2.9</td>
<td align="center" valign="top">31.1&#x02009;&#x000B1;&#x02009;2.2</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.809</td>
</tr>
<tr>
<td align="left" valign="top">OPL</td>
<td align="center" valign="top">27.4&#x02009;&#x000B1;&#x02009;3.3</td>
<td align="center" valign="top">26.9&#x02009;&#x000B1;&#x02009;2.0</td>
<td align="center" valign="top"><bold>0.044</bold></td>
<td align="center" valign="top">0.613</td>
</tr>
<tr>
<td align="left" valign="top">ONL</td>
<td align="center" valign="top">58.2&#x02009;&#x000B1;&#x02009;11.2</td>
<td align="center" valign="top">53.6&#x02009;&#x000B1;&#x02009;8.0</td>
<td align="center" valign="top">0.086</td>
<td align="center" valign="top">0.577</td>
</tr>
<tr>
<td align="left" valign="top">PRL</td>
<td align="center" valign="top">79.7&#x02009;&#x000B1;&#x02009;2.9</td>
<td align="center" valign="top">78.2&#x02009;&#x000B1;&#x02009;2.3</td>
<td align="center" valign="top"><bold>0.031</bold></td>
<td align="center" valign="top">0.654</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Superotemporal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">RNFL</td>
<td align="center" valign="top">18.8&#x02009;&#x000B1;&#x02009;2.6</td>
<td align="center" valign="top">20.2&#x02009;&#x000B1;&#x02009;2.2</td>
<td align="center" valign="top"><bold>0.046</bold></td>
<td align="center" valign="top">0.654</td>
</tr>
<tr>
<td align="left" valign="top">GCL</td>
<td align="center" valign="top">26.6&#x02009;&#x000B1;&#x02009;4.6</td>
<td align="center" valign="top">33.5&#x02009;&#x000B1;&#x02009;4.6</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.896</td>
</tr>
<tr>
<td align="left" valign="top">IPL</td>
<td align="center" valign="top">24.8&#x02009;&#x000B1;&#x02009;3.1</td>
<td align="center" valign="top">28.5&#x02009;&#x000B1;&#x02009;2.2</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.837</td>
</tr>
<tr>
<td align="left" valign="top">INL</td>
<td align="center" valign="top">31.2&#x02009;&#x000B1;&#x02009;2.4</td>
<td align="center" valign="top">30.4&#x02009;&#x000B1;&#x02009;1.9</td>
<td align="center" valign="top">0.181</td>
<td align="center" valign="top">0.619</td>
</tr>
<tr>
<td align="left" valign="top">OPL</td>
<td align="center" valign="top">26.1&#x02009;&#x000B1;&#x02009;2.1</td>
<td align="center" valign="top">25.6&#x02009;&#x000B1;&#x02009;1.4</td>
<td align="center" valign="top">0.263</td>
<td align="center" valign="top">0.563</td>
</tr>
<tr>
<td align="left" valign="top">ONL</td>
<td align="center" valign="top">58.0&#x02009;&#x000B1;&#x02009;4.4</td>
<td align="center" valign="top">58.6&#x02009;&#x000B1;&#x02009;7.7</td>
<td align="center" valign="top">0.725</td>
<td align="center" valign="top">0.404</td>
</tr>
<tr>
<td align="left" valign="top">PRL</td>
<td align="center" valign="top">79.9&#x02009;&#x000B1;&#x02009;2.9</td>
<td align="center" valign="top">79.2&#x02009;&#x000B1;&#x02009;2.3</td>
<td align="center" valign="top">0.349</td>
<td align="center" valign="top">0.570</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Inferotemporal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">RNFL</td>
<td align="center" valign="top">22.4&#x02009;&#x000B1;&#x02009;4.2</td>
<td align="center" valign="top">25.6&#x02009;&#x000B1;&#x02009;4.1</td>
<td align="center" valign="top"><bold>0.002</bold></td>
<td align="center" valign="top">0.717</td>
</tr>
<tr>
<td align="left" valign="top">GCL</td>
<td align="center" valign="top">27.8&#x02009;&#x000B1;&#x02009;4.2</td>
<td align="center" valign="top">33.3&#x02009;&#x000B1;&#x02009;2.8</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.870</td>
</tr>
<tr>
<td align="left" valign="top">IPL</td>
<td align="center" valign="top">24.0&#x02009;&#x000B1;&#x02009;2.9</td>
<td align="center" valign="top">27.5&#x02009;&#x000B1;&#x02009;2.3</td>
<td align="center" valign="top"><bold>&#x0003C;0.001</bold></td>
<td align="center" valign="top">0.833</td>
</tr>
<tr>
<td align="left" valign="top">INL</td>
<td align="center" valign="top">30.9&#x02009;&#x000B1;&#x02009;2.2</td>
<td align="center" valign="top">30.3&#x02009;&#x000B1;&#x02009;2.0</td>
<td align="center" valign="top">0.286</td>
<td align="center" valign="top">0.595</td>
</tr>
<tr>
<td align="left" valign="top">OPL</td>
<td align="center" valign="top">25.7&#x02009;&#x000B1;&#x02009;1.6</td>
<td align="center" valign="top">25.4&#x02009;&#x000B1;&#x02009;1.5</td>
<td align="center" valign="top">0.572</td>
<td align="center" valign="top">0.549</td>
</tr>
<tr>
<td align="left" valign="top">ONL</td>
<td align="center" valign="top">54.8&#x02009;&#x000B1;&#x02009;8.0</td>
<td align="center" valign="top">54.3&#x02009;&#x000B1;&#x02009;7.4</td>
<td align="center" valign="top">0.782</td>
<td align="center" valign="top">0.423</td>
</tr>
<tr>
<td align="left" valign="top">PRL</td>
<td align="center" valign="top">79.1&#x02009;&#x000B1;&#x02009;2.6</td>
<td align="center" valign="top">78.6&#x02009;&#x000B1;&#x02009;2.5</td>
<td align="center" valign="top">0.481</td>
<td align="center" valign="top">0.553</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1"><p><italic><sup>a</sup>Generalized estimating equations</italic>.</p></fn>
<p><italic>Significant values are in bold</italic>.</p>
<p><italic>AUC, area under the receiver operating characteristic curve; RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer</italic>.</p></table-wrap-foot></table-wrap>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>10-2 visual field pattern deviation plot, local responses on regular and slow-flash mfERG and pseudocolor thickness maps generated from the posterior pole OCT scan, based on the thickness of the layers evaluated. <bold>(A)</bold> Patient with band atrophy and temporal hemianopia. Note the amplitude reduction in the nasal sectors on slow-flash mfERG and concomitant increase in outer layer thickness. <bold>(B)</bold> Normal control.</p></caption>
<graphic xlink:href="fneur-08-00619-g005.tif"/>
</fig>
<p>Table <xref ref-type="table" rid="T2">2</xref> and Figure <xref ref-type="fig" rid="F6">6</xref> show the results of both regular and SF-mfERG measurements in different quadrants and hemifields of BA eyes and controls. When compared to normals, BA patients had significantly lower mean OP amplitudes in both the nasal and temporal hemiretinas, but no significant difference was found between quadrantic measurements. In BA eyes, the averaged sum of the three positive wavelets was 17.0&#x02009;&#x000B1;&#x02009;5.1 for the nasal hemiretina and 16.8&#x02009;&#x000B1;&#x02009;5.8 for the temporal hemiretina, compared to 19.5&#x02009;&#x000B1;&#x02009;4.7 and 20.1&#x02009;&#x000B1;&#x02009;5.8 in control eyes, respectively. The reduction in N1 and P1 amplitude observed in all quadrants on regular flash mfERG was non-significant except for N1 amplitude in the IN quadrant of BA eyes.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Mean amplitudes (&#x000B1;SD) of multifocal OPs and multifocal ERG parameters (in nV/deg).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Parameter</th>
<th valign="top" align="center">Band atrophy</th>
<th valign="top" align="center">Controls</th>
<th valign="top" align="center"><italic>P</italic> value<xref ref-type="table-fn" rid="tfn2"><sup>a</sup></xref></th>
<th valign="top" align="center">AUC</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="5"><bold>Superonasal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">mOP</td>
<td align="center" valign="top">19.6&#x02009;&#x000B1;&#x02009;6.8</td>
<td align="center" valign="top">21.5&#x02009;&#x000B1;&#x02009;5.4</td>
<td align="center" valign="top">0.203</td>
<td align="center" valign="top">0.599</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1 amplitude</td>
<td align="center" valign="top">9.1&#x02009;&#x000B1;&#x02009;3.9</td>
<td align="center" valign="top">9.0&#x02009;&#x000B1;&#x02009;3.4</td>
<td align="center" valign="top">0.901</td>
<td align="center" valign="top">0.522</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1 amplitude</td>
<td align="center" valign="top">36.0&#x02009;&#x000B1;&#x02009;10.7</td>
<td align="center" valign="top">35.8&#x02009;&#x000B1;&#x02009;6.9</td>
<td align="center" valign="top">0.951</td>
<td align="center" valign="top">0.503</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Inferonasal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">mOP</td>
<td align="center" valign="top">18.0&#x02009;&#x000B1;&#x02009;5.8</td>
<td align="center" valign="top">19.1&#x02009;&#x000B1;&#x02009;5.5</td>
<td align="center" valign="top">0.437</td>
<td align="center" valign="top">0.570</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1 amplitude</td>
<td align="center" valign="top">7.4&#x02009;&#x000B1;&#x02009;3.0</td>
<td align="center" valign="top">8.8&#x02009;&#x000B1;&#x02009;2.6</td>
<td align="center" valign="top"><bold>0.045</bold></td>
<td align="center" valign="top">0.679</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1 amplitude</td>
<td align="center" valign="top">31.3&#x02009;&#x000B1;&#x02009;9.4</td>
<td align="center" valign="top">35.0&#x02009;&#x000B1;&#x02009;8.0</td>
<td align="center" valign="top">0.104</td>
<td align="center" valign="top">0.645</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Superotemporal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">mOP</td>
<td align="center" valign="top">20.7&#x02009;&#x000B1;&#x02009;6.1</td>
<td align="center" valign="top">23.2&#x02009;&#x000B1;&#x02009;7.2</td>
<td align="center" valign="top">0.114</td>
<td align="center" valign="top">0.605</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1 amplitude</td>
<td align="center" valign="top">8.6&#x02009;&#x000B1;&#x02009;3.9</td>
<td align="center" valign="top">9.5&#x02009;&#x000B1;&#x02009;3.6</td>
<td align="center" valign="top">0.363</td>
<td align="center" valign="top">0.580</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1 amplitude</td>
<td align="center" valign="top">35.3&#x02009;&#x000B1;&#x02009;9.8</td>
<td align="center" valign="top">37.0&#x02009;&#x000B1;&#x02009;6.3</td>
<td align="center" valign="top">0.444</td>
<td align="center" valign="top">0.555</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Inferotemporal quadrant</bold></td>
</tr>
<tr>
<td align="left" valign="top">mOP</td>
<td align="center" valign="top">17.7&#x02009;&#x000B1;&#x02009;6.9</td>
<td align="center" valign="top">17.8&#x02009;&#x000B1;&#x02009;6.0</td>
<td align="center" valign="top">0.201</td>
<td align="center" valign="top">0.613</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1 amplitude</td>
<td align="center" valign="top">7.9&#x02009;&#x000B1;&#x02009;3.1</td>
<td align="center" valign="top">9.6&#x02009;&#x000B1;&#x02009;3.5</td>
<td align="center" valign="top">0.063</td>
<td align="center" valign="top">0.649</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1 amplitude</td>
<td align="center" valign="top">32.0&#x02009;&#x000B1;&#x02009;8.6</td>
<td align="center" valign="top">36.0&#x02009;&#x000B1;&#x02009;8.0</td>
<td align="center" valign="top">0.059</td>
<td align="center" valign="top">0.657</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Nasal hemiretina</bold></td>
</tr>
<tr>
<td align="left" valign="top">mOP</td>
<td align="center" valign="top">17.0&#x02009;&#x000B1;&#x02009;5.1</td>
<td align="center" valign="top">19.5&#x02009;&#x000B1;&#x02009;4.7</td>
<td align="center" valign="top"><bold>0.029</bold></td>
<td align="center" valign="top">0.651</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1 amplitude</td>
<td align="center" valign="top">8.6&#x02009;&#x000B1;&#x02009;3.5</td>
<td align="center" valign="top">9.1&#x02009;&#x000B1;&#x02009;2.6</td>
<td align="center" valign="top">0.506</td>
<td align="center" valign="top">0.602</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1 amplitude</td>
<td align="center" valign="top">34.4&#x02009;&#x000B1;&#x02009;9.9</td>
<td align="center" valign="top">36.4&#x02009;&#x000B1;&#x02009;7.4</td>
<td align="center" valign="top">0.373</td>
<td align="center" valign="top">0.582</td>
</tr>
<tr>
<td align="left" valign="top" colspan="5"><bold>Temporal hemiretina</bold></td>
</tr>
<tr>
<td align="left" valign="top">mOP</td>
<td align="center" valign="top">16.8&#x02009;&#x000B1;&#x02009;5.0</td>
<td align="center" valign="top">20.1&#x02009;&#x000B1;&#x02009;5.8</td>
<td align="center" valign="top"><bold>0.013</bold></td>
<td align="center" valign="top">0.679</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1 amplitude</td>
<td align="center" valign="top">8.5&#x02009;&#x000B1;&#x02009;3.3</td>
<td align="center" valign="top">9.8&#x02009;&#x000B1;&#x02009;3.3</td>
<td align="center" valign="top">0.136</td>
<td align="center" valign="top">0.638</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1 amplitude</td>
<td align="center" valign="top">34.5&#x02009;&#x000B1;&#x02009;9.0</td>
<td align="center" valign="top">37.5&#x02009;&#x000B1;&#x02009;7.2</td>
<td align="center" valign="top">0.167</td>
<td align="center" valign="top">0.616</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2"><p><italic><sup>a</sup>Generalized estimating equations</italic>.</p></fn>
<p><italic>Significant values in bold</italic>.</p>
<p><italic>AUC, area under the receiver operating characteristic curve; OP, oscillatory potentials; ERG, electroretinography</italic>.</p></table-wrap-foot></table-wrap>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Boxplots of mean values of oscillatory potentials (OP) on slow-flash mfERG and of N1 and P1 amplitudes on regular flash mfERG. Note that the average OP amplitudes of the nasal and temporal hemiretinas were significantly lower in patients with BA than in normal controls. Average N1 amplitude was reduced in the inferonasal quadrant. &#x0002A;<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.001 (GEE).</p></caption>
<graphic xlink:href="fneur-08-00619-g006.tif"/>
</fig>
<p>Table <xref ref-type="table" rid="T3">3</xref> shows the correlations between the thickness of each retinal layer and mean VF sensitivity (1/L) per quadrant on 10-2 SAP. Significant correlations were found between macular thickness (RNFL, GCL, IPL, INL, and PRL) in the nasal quadrants and VF parameters in the temporal quadrants. Correlations with 10-2 sensitivity were positive for RNFL, GCL, and IPL and negative for INL and PRL measurements. The strongest correlations were between GCL thickness in the IN quadrant and VF sensitivity in the ST quadrant (0.831, <italic>P</italic>&#x02009;&#x0003C;&#x02009;0.01) and between GCL thickness in the SN quadrant and VF sensitivity in the IT quadrant (0.821, <italic>P</italic>&#x02009;&#x0003C;&#x02009;0.01).</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Correlation between spectralis OCT segmented macular thickness parameters (in micrometers) and mean 10-2 visual field sensitivity parameters (in 1/Lambert).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left" rowspan="2">OCT parameters</th>
<th valign="top" align="center" colspan="6">10-2 Visual field<hr/></th>
</tr><tr>
<th valign="top" align="center">SN</th>
<th valign="top" align="center">IN</th>
<th valign="top" align="center">ST</th>
<th valign="top" align="center">IT</th>
<th valign="top" align="center">Nasal</th>
<th valign="top" align="center">Temporal</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="7"><bold>RNFL</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superonasal quadrant</td>
<td align="center" valign="top"><underline>0.25</underline></td>
<td align="center" valign="top"><bold>0.32</bold></td>
<td align="center" valign="top"><bold>0.68</bold></td>
<td align="center" valign="top"><bold>0.72</bold></td>
<td align="center" valign="top"><bold>0.46</bold></td>
<td align="center" valign="top"><bold>0.72</bold></td>
</tr>
<tr>
<td align="left" valign="top">Inferonasal quadrant</td>
<td align="center" valign="top"><bold>0.30</bold></td>
<td align="center" valign="top"><underline>0.26</underline></td>
<td align="center" valign="top"><bold>0.70</bold></td>
<td align="center" valign="top"><bold>0.72</bold></td>
<td align="center" valign="top"><bold>0.51</bold></td>
<td align="center" valign="top"><bold>0.74</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superotemporal quadrant</td>
<td align="center" valign="top"><underline>0.23</underline></td>
<td align="center" valign="top">0.18</td>
<td align="center" valign="top"><bold>0.30</bold></td>
<td align="center" valign="top"><bold>0.36</bold></td>
<td align="center" valign="top"><bold>0.42</bold></td>
<td align="center" valign="top"><bold>0.38</bold></td>
</tr>
<tr>
<td align="left" valign="top">Inferotemporal quadrant</td>
<td align="center" valign="top"><underline>0.27</underline></td>
<td align="center" valign="top">0.16</td>
<td align="center" valign="top"><bold>0.44</bold></td>
<td align="center" valign="top"><bold>0.45</bold></td>
<td align="center" valign="top"><bold>0.47</bold></td>
<td align="center" valign="top"><bold>0.49</bold></td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>GCL</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superonasal quadrant</td>
<td align="center" valign="top"><bold>0.29</bold></td>
<td align="center" valign="top"><bold>0.42</bold></td>
<td align="center" valign="top"><bold>0.83</bold></td>
<td align="center" valign="top"><bold>0.82</bold></td>
<td align="center" valign="top"><bold>0.42</bold></td>
<td align="center" valign="top"><bold>0.83</bold></td>
</tr>
<tr>
<td align="left" valign="top">Inferonasal quadrant</td>
<td align="center" valign="top"><underline>0.26</underline></td>
<td align="center" valign="top"><bold>0.40</bold></td>
<td align="center" valign="top"><bold>0.83</bold></td>
<td align="center" valign="top"><bold>0.80</bold></td>
<td align="center" valign="top"><bold>0.37</bold></td>
<td align="center" valign="top"><bold>0.81</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superotemporal quadrant</td>
<td align="center" valign="top"><bold>0.32</bold></td>
<td align="center" valign="top"><bold>0.34</bold></td>
<td align="center" valign="top"><bold>0.61</bold></td>
<td align="center" valign="top"><bold>0.64</bold></td>
<td align="center" valign="top"><bold>0.52</bold></td>
<td align="center" valign="top"><bold>0.65</bold></td>
</tr>
<tr>
<td align="left" valign="top">Inferotemporal quadrant</td>
<td align="center" valign="top"><bold>0.44</bold></td>
<td align="center" valign="top"><bold>0.36</bold></td>
<td align="center" valign="top"><bold>0.71</bold></td>
<td align="center" valign="top"><bold>0.71</bold></td>
<td align="center" valign="top"><bold>0.60</bold></td>
<td align="center" valign="top"><bold>0.74</bold></td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>IPL</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superonasal quadrant</td>
<td align="center" valign="top"><underline>0.22</underline></td>
<td align="center" valign="top"><bold>0.38</bold></td>
<td align="center" valign="top"><bold>0.81</bold></td>
<td align="center" valign="top"><bold>0.77</bold></td>
<td align="center" valign="top"><bold>0.30</bold></td>
<td align="center" valign="top"><bold>0.79</bold></td>
</tr>
<tr>
<td align="left" valign="top">Inferonasal quadrant</td>
<td align="center" valign="top">0.16</td>
<td align="center" valign="top"><bold>0.38</bold></td>
<td align="center" valign="top"><bold>0.79</bold></td>
<td align="center" valign="top"><bold>0.74</bold></td>
<td align="center" valign="top"><underline>0.26</underline></td>
<td align="center" valign="top"><bold>0.75</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superotemporal quadrant</td>
<td align="center" valign="top"><bold>0.35</bold></td>
<td align="center" valign="top"><bold>0.33</bold></td>
<td align="center" valign="top"><bold>0.65</bold></td>
<td align="center" valign="top"><bold>0.65</bold></td>
<td align="center" valign="top"><bold>0.53</bold></td>
<td align="center" valign="top"><bold>0.69</bold></td>
</tr>
<tr>
<td align="left" valign="top">Inferotemporal quadrant</td>
<td align="center" valign="top"><bold>0.35</bold></td>
<td align="center" valign="top"><bold>0.30</bold></td>
<td align="center" valign="top"><bold>0.67</bold></td>
<td align="center" valign="top"><bold>0.66</bold></td>
<td align="center" valign="top"><bold>0.48</bold></td>
<td align="center" valign="top"><bold>0.70</bold></td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>INL</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superonasal quadrant</td>
<td align="center" valign="top">&#x02212;0.11</td>
<td align="center" valign="top">&#x02212;0.11</td>
<td align="center" valign="top">&#x02212;<underline>0.26</underline></td>
<td align="center" valign="top">&#x02212;<underline>0.28</underline></td>
<td align="center" valign="top">&#x02212;0.21</td>
<td align="center" valign="top">&#x02212;<underline>0.25</underline></td>
</tr>
<tr>
<td align="left" valign="top">Inferonasal quadrant</td>
<td align="center" valign="top">&#x02212;0.18</td>
<td align="center" valign="top">&#x02212;0.18</td>
<td align="center" valign="top">&#x02212;<bold>0.49</bold></td>
<td align="center" valign="top">&#x02212;<bold>0.48</bold></td>
<td align="center" valign="top">&#x02212;<bold>0.31</bold></td>
<td align="center" valign="top">&#x02212;<bold>0.46</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superotemporal quadrant</td>
<td align="center" valign="top">0.05</td>
<td align="center" valign="top">&#x02212;0.06</td>
<td align="center" valign="top">&#x02212;0.12</td>
<td align="center" valign="top">&#x02212;0.09</td>
<td align="center" valign="top">&#x02212;0.05</td>
<td align="center" valign="top">&#x02212;0.06</td>
</tr>
<tr>
<td align="left" valign="top">Inferotemporal quadrant</td>
<td align="center" valign="top">0.04</td>
<td align="center" valign="top">0.01</td>
<td align="center" valign="top">&#x02212;0.08</td>
<td align="center" valign="top">&#x02212;0.04</td>
<td align="center" valign="top">&#x02212;0.05</td>
<td align="center" valign="top">&#x02212;0.02</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>OPL</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superonasal quadrant</td>
<td align="center" valign="top">&#x02212;0.01</td>
<td align="center" valign="top">0.02</td>
<td align="center" valign="top">&#x02212;0.18</td>
<td align="center" valign="top">&#x02212;<underline>0.22</underline></td>
<td align="center" valign="top">&#x02212;0.07</td>
<td align="center" valign="top">&#x02212;0.19</td>
</tr>
<tr>
<td align="left" valign="top">Inferonasal quadrant</td>
<td align="center" valign="top">&#x02212;0.00</td>
<td align="center" valign="top">0.07</td>
<td align="center" valign="top">&#x02212;0.07</td>
<td align="center" valign="top">&#x02212;0.12</td>
<td align="center" valign="top">&#x02212;0.03</td>
<td align="center" valign="top">&#x02212;0.11</td>
</tr>
<tr>
<td align="left" valign="top">Superotemporal quadrant</td>
<td align="center" valign="top">0.01</td>
<td align="center" valign="top">0.10</td>
<td align="center" valign="top">&#x02212;0.17</td>
<td align="center" valign="top">&#x02212;0.17</td>
<td align="center" valign="top">&#x02212;0.07</td>
<td align="center" valign="top">&#x02212;0.11</td>
</tr>
<tr>
<td align="left" valign="top">Inferotemporal quadrant</td>
<td align="center" valign="top">0.00</td>
<td align="center" valign="top">0.12</td>
<td align="center" valign="top">&#x02212;0.11</td>
<td align="center" valign="top">&#x02212;0.09</td>
<td align="center" valign="top">&#x02212;0.05</td>
<td align="center" valign="top">&#x02212;0.08</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>ONL</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superonasal quadrant</td>
<td align="center" valign="top">0.01</td>
<td align="center" valign="top">&#x02212;0.02</td>
<td align="center" valign="top">&#x02212;0.13</td>
<td align="center" valign="top">&#x02212;0.11</td>
<td align="center" valign="top">&#x02212;0.06</td>
<td align="center" valign="top">&#x02212;0.15</td>
</tr>
<tr>
<td align="left" valign="top">Inferonasal quadrant</td>
<td align="center" valign="top">&#x02212;0.08</td>
<td align="center" valign="top">&#x02212;0.07</td>
<td align="center" valign="top">&#x02212;0.14</td>
<td align="center" valign="top">&#x02212;0.12</td>
<td align="center" valign="top">&#x02212;0.14</td>
<td align="center" valign="top">&#x02212;0.15</td>
</tr>
<tr>
<td align="left" valign="top">Superotemporal quadrant</td>
<td align="center" valign="top">0.04</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">0.07</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">0.02</td>
<td align="center" valign="top">0.03</td>
</tr>
<tr>
<td align="left" valign="top">Inferotemporal quadrant</td>
<td align="center" valign="top">0.02</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">&#x02212;0.02</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">0.01</td>
<td align="center" valign="top">0.02</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>PRL</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superonasal quadrant</td>
<td align="center" valign="top">&#x02212;0.12</td>
<td align="center" valign="top">&#x02212;0.14</td>
<td align="center" valign="top">&#x02212;<bold>0.29</bold></td>
<td align="center" valign="top">&#x02212;<bold>0.29</bold></td>
<td align="center" valign="top">&#x02212;0.09</td>
<td align="center" valign="top">&#x02212;<bold>0.29</bold></td>
</tr>
<tr>
<td align="left" valign="top">Inferonasal quadrant</td>
<td align="center" valign="top">&#x02212;0.08</td>
<td align="center" valign="top">&#x02212;0.11</td>
<td align="center" valign="top">&#x02212;<underline>0.27</underline></td>
<td align="center" valign="top">&#x02212;<bold>0.27</bold></td>
<td align="center" valign="top">&#x02212;0.07</td>
<td align="center" valign="top">&#x02212;<bold>0.31</bold></td>
</tr>
<tr>
<td align="left" valign="top">Superotemporal quadrant</td>
<td align="center" valign="top">&#x02212;0.13</td>
<td align="center" valign="top">&#x02212;0.14</td>
<td align="center" valign="top">&#x02212;0.18</td>
<td align="center" valign="top">&#x02212;0.19</td>
<td align="center" valign="top">&#x02212;0.12</td>
<td align="center" valign="top">&#x02212;0.19</td>
</tr>
<tr>
<td align="left" valign="top">Inferotemporal quadrant</td>
<td align="center" valign="top">&#x02212;0.12</td>
<td align="center" valign="top">&#x02212;0.14</td>
<td align="center" valign="top">&#x02212;0.15</td>
<td align="center" valign="top">&#x02212;0.16</td>
<td align="center" valign="top">&#x02212;0.08</td>
<td align="center" valign="top">&#x02212;0.16</td>
</tr>
</tbody>
</table>
<table-wrap-foot><p><italic>Pearson&#x02019;s correlation coefficient. Underline type&#x02009;&#x0003D;&#x02009;P&#x02009;&#x0003C;&#x02009;0.05; bold type&#x02009;&#x0003D;&#x02009;P&#x02009;&#x0003C;&#x02009;0.01</italic>.</p>
<p><italic>OCT, optical coherence tomography; SN, superonasal quadrant; IN, inferonasal quadrant; ST, superotemporal quadrant; IT, inferotemporal quadrant; RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer</italic>.</p></table-wrap-foot></table-wrap>
<p>The results of the Spearman correlation analysis between segmented macular thickness and electrophysiological measurements are shown in Table <xref ref-type="table" rid="T4">4</xref>. A positive significant correlation was found only between OP amplitude and INL thickness in the SN quadrant.</p>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p>Correlation between spectralis OCT segmented macular thickness parameters (in micrometers) in quadrants and hemiretinas and their respective OPs on slow-flash mfERG and amplitudes (nV/deg) on regular mfERG.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Electrophysiology parameters</th>
<th valign="top" align="center" colspan="6">OCT parameters<hr/></th>
</tr><tr>
<th valign="top" align="center">SN</th>
<th valign="top" align="center">IN</th>
<th valign="top" align="center">ST</th>
<th valign="top" align="center">IT</th>
<th valign="top" align="center">Nasal</th>
<th valign="top" align="center">Temporal</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="7"><bold>RNFL</bold></td>
</tr>
<tr>
<td align="left" valign="top">OP</td>
<td align="center" valign="top">0.213</td>
<td align="center" valign="top">0.201</td>
<td align="center" valign="top">0.124</td>
<td align="center" valign="top">0.144</td>
<td align="center" valign="top"><underline>0.28</underline></td>
<td align="center" valign="top">0.19</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">0.20</td>
<td align="center" valign="top">&#x02212;0.05</td>
<td align="center" valign="top">0.11</td>
<td align="center" valign="top">0.12</td>
<td align="center" valign="top">0.09</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1</td>
<td align="center" valign="top">0.09</td>
<td align="center" valign="top">0.21</td>
<td align="center" valign="top">&#x02212;0.11</td>
<td align="center" valign="top">0.08</td>
<td align="center" valign="top">0.15</td>
<td align="center" valign="top">0.02</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>GCL</bold></td>
</tr>
<tr>
<td align="left" valign="top">OP</td>
<td align="center" valign="top">0.17</td>
<td align="center" valign="top">0.22</td>
<td align="center" valign="top"><underline>0.25</underline></td>
<td align="center" valign="top"><underline>0.28</underline></td>
<td align="center" valign="top"><bold>0.31</bold></td>
<td align="center" valign="top"><bold>0.33</bold></td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1</td>
<td align="center" valign="top">0.04</td>
<td align="center" valign="top"><bold>0.34</bold></td>
<td align="center" valign="top">0.14</td>
<td align="center" valign="top">0.17</td>
<td align="center" valign="top">0.18</td>
<td align="center" valign="top">0.17</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1</td>
<td align="center" valign="top">0.13</td>
<td align="center" valign="top"><bold>0.29</bold></td>
<td align="center" valign="top">0.15</td>
<td align="center" valign="top">0.19</td>
<td align="center" valign="top">0.22</td>
<td align="center" valign="top">0.17</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>IPL</bold></td>
</tr>
<tr>
<td align="left" valign="top">OP</td>
<td align="center" valign="top">0.10</td>
<td align="center" valign="top">0.17</td>
<td align="center" valign="top">0.17</td>
<td align="center" valign="top">0.19</td>
<td align="center" valign="top"><underline>0.26</underline></td>
<td align="center" valign="top"><underline>0.23</underline></td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1</td>
<td align="center" valign="top">0.38</td>
<td align="center" valign="top"><bold>0.37</bold></td>
<td align="center" valign="top">0.08</td>
<td align="center" valign="top">0.13</td>
<td align="center" valign="top">0.18</td>
<td align="center" valign="top">0.12</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1</td>
<td align="center" valign="top">0.14</td>
<td align="center" valign="top"><bold>0.30</bold></td>
<td align="center" valign="top">0.09</td>
<td align="center" valign="top">0.12</td>
<td align="center" valign="top">0.22</td>
<td align="center" valign="top">0.12</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>INL</bold></td>
</tr>
<tr>
<td align="left" valign="top">OP</td>
<td align="center" valign="top"><underline>0.23</underline></td>
<td align="center" valign="top">0.03</td>
<td align="center" valign="top">0.10</td>
<td align="center" valign="top">0.12</td>
<td align="center" valign="top">&#x02212;0.19</td>
<td align="center" valign="top">0.04</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1</td>
<td align="center" valign="top">&#x02212;0.05</td>
<td align="center" valign="top">0.02</td>
<td align="center" valign="top">0.09</td>
<td align="center" valign="top">0.10</td>
<td align="center" valign="top">&#x02212;0.01</td>
<td align="center" valign="top">0.08</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1</td>
<td align="center" valign="top">0.10</td>
<td align="center" valign="top">0.04</td>
<td align="center" valign="top">0.11</td>
<td align="center" valign="top">0.16</td>
<td align="center" valign="top">0.05</td>
<td align="center" valign="top">0.16</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>OPL</bold></td>
</tr>
<tr>
<td align="left" valign="top">OP</td>
<td align="center" valign="top">&#x02212;0.03</td>
<td align="center" valign="top">0.10</td>
<td align="center" valign="top">&#x02212;0.09</td>
<td align="center" valign="top">0.00</td>
<td align="center" valign="top">0.09</td>
<td align="center" valign="top">0.02</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1</td>
<td align="center" valign="top">&#x02212;0.00</td>
<td align="center" valign="top">&#x02212;0.02</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">0.07</td>
<td align="center" valign="top">0.01</td>
<td align="center" valign="top">0.05</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1</td>
<td align="center" valign="top">0.09</td>
<td align="center" valign="top">0.14</td>
<td align="center" valign="top">0.09</td>
<td align="center" valign="top">0.12</td>
<td align="center" valign="top">0.09</td>
<td align="center" valign="top">0.08</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>ONL</bold></td>
</tr>
<tr>
<td align="left" valign="top">OP</td>
<td align="center" valign="top">&#x02212;0.11</td>
<td align="center" valign="top">&#x02212;0.07</td>
<td align="center" valign="top">0.01</td>
<td align="center" valign="top">&#x02212;0.03</td>
<td align="center" valign="top">&#x02212;0.15</td>
<td align="center" valign="top">0.03</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1</td>
<td align="center" valign="top">0.14</td>
<td align="center" valign="top">&#x02212;0.08</td>
<td align="center" valign="top">0.19</td>
<td align="center" valign="top"><underline>0.23</underline></td>
<td align="center" valign="top">&#x02212;0.03</td>
<td align="center" valign="top">0.23</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1</td>
<td align="center" valign="top">0.13</td>
<td align="center" valign="top">&#x02212;0.01</td>
<td align="center" valign="top"><underline>0.24</underline></td>
<td align="center" valign="top">0.11</td>
<td align="center" valign="top">&#x02212;0.06</td>
<td align="center" valign="top">0.18</td>
</tr>
<tr>
<td align="left" valign="top" colspan="7"><bold>PRL</bold></td>
</tr>
<tr>
<td align="left" valign="top">OP</td>
<td align="center" valign="top">&#x02212;0.14</td>
<td align="center" valign="top">&#x02212;0.10</td>
<td align="center" valign="top">0.01</td>
<td align="center" valign="top">&#x02212;0.01</td>
<td align="center" valign="top">&#x02212;0.18</td>
<td align="center" valign="top">&#x02212;0.03</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;N1</td>
<td align="center" valign="top">&#x02212;0.06</td>
<td align="center" valign="top">&#x02212;0.14</td>
<td align="center" valign="top">&#x02212;0.06</td>
<td align="center" valign="top">&#x02212;0.15</td>
<td align="center" valign="top">&#x02212;0.12</td>
<td align="center" valign="top">&#x02212;0.12</td>
</tr>
<tr>
<td align="left" valign="top">mfERG&#x02013;P1</td>
<td align="center" valign="top">0.10</td>
<td align="center" valign="top">&#x02212;0.21</td>
<td align="center" valign="top">&#x02212;0.01</td>
<td align="center" valign="top">&#x02212;0.10</td>
<td align="center" valign="top">0.03</td>
<td align="center" valign="top">&#x02212;0.07</td>
</tr>
</tbody>
</table>
<table-wrap-foot><p><italic>Spearman&#x02019;s correlation coefficient. Underline type&#x02009;&#x0003D;&#x02009;P&#x02009;&#x0003C;&#x02009;0.05; bold type&#x02009;&#x0003D;&#x02009;P&#x02009;&#x0003C;&#x02009;0.01</italic>.</p>
<p><italic>OCT, optical coherence tomography; SN, superonasal quadrant; IN, inferonasal quadrant; ST, superotemporal quadrant; IT, inferotemporal quadrant; OP, oscillatory potential; RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer; mfERG, multifocal electroretinography</italic>.</p></table-wrap-foot></table-wrap>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>Our findings confirm that in patients with sequel temporal hemianopia due to chiasmal compression, RNFL, GCL, and IPL thickness is reduced not only in the nasal quadrants but also, to a certain extent, in the temporal quadrants of the macular area (Table <xref ref-type="table" rid="T1">1</xref>). Despite the rationale that our patients with temporal hemianopia and nasal VF within normal limits should have normal uncrossed nerve fibers and normal retinal structures temporal to the macula, we found reduced inner retinal layers in both the nasal and the temporal hemiretina, matching previous studies in similar sets of patients (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B55">55</xref>).</p>
<p>Presumably, damage to the retinal ganglion cell (RGC) and retinal nerve fibers originating in the temporal hemiretina occurred before chiasmal decompression, and although the nasal VF was labeled as being within normal limits at the time of the study, some subclinical damage already existed in the temporal retina. Despite this limitation, our model is interesting in that it allows to compare clearly (often severely) affected nasal hemiretinas to relatively preserved temporal hemiretinas. Therefore, the model seems valid for the main purpose of the current study that was to investigate structural and functional changes in retinal layers other than the RNFL and the GCL in patients with temporal hemianopia from previous chiasmal compression.</p>
<p>In a previous study, increased INL thickness (measured together with the OPL) in segmented SD-OCT measurements in patients with chiasmal compression was limited to the nasal hemiretina (<xref ref-type="bibr" rid="B22">22</xref>). This observation was confirmed in the present study by the finding of increased thickness in both the INL and OPL (measured separately), supporting the notion that primary damage to the RNFL and GCL caused by axonal degeneration from chiasmal compression is associated with secondary structural abnormalities in the INL (Table <xref ref-type="table" rid="T1">1</xref>). We also observed functional abnormalities at the level of the INL, as indicated by the significantly lower mean mfOP amplitude in the affected nasal hemiretina (Table <xref ref-type="table" rid="T2">2</xref>). To enhance the OP components from specific areas of the macula, we used SF-mfERG (inserting periods of darkness between the stimuli). Previous pharmacological (<xref ref-type="bibr" rid="B28">28</xref>) and clinical (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>) studies suggest that mfOPs are a sign of INL cell activity (especially from amacrine and bipolar cells), with some influence of rod and cone interaction (<xref ref-type="bibr" rid="B31">31</xref>). Decreased mfOP amplitude has been documented in other conditions known to affect the inner retina, such as diabetic retinopathy (<xref ref-type="bibr" rid="B35">35</xref>), progressive myopia (<xref ref-type="bibr" rid="B32">32</xref>), and glaucoma (<xref ref-type="bibr" rid="B37">37</xref>). The current study is the first to document reduced mfOP values on SF-mfERG along with abnormal OCT structural measurements in the INL of BA patients (Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>). In a previous study, increased INL thickness in the nasal retina of BA patients was associated with a high incidence of microcystic INL abnormalities (<xref ref-type="bibr" rid="B22">22</xref>), a phenomenon observed in studies on other optic neuropathies (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B58">58</xref>&#x02013;<xref ref-type="bibr" rid="B60">60</xref>). In such studies, retinal microcysts were more prominent in the parafoveal area, corresponding to the area with the largest concentration of both M&#x000FC;ller and ganglion cells (<xref ref-type="bibr" rid="B61">61</xref>). Researchers (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B62">62</xref>) have suggested that vitreous traction could be associated with the occurrence of INL microcysts, but we find it an unlikely pathogenic factor, since in a previous study, the microcysts were restricted to the nasal hemiretina of eyes with temporal hemianopia and BA of the optic nerve (<xref ref-type="bibr" rid="B22">22</xref>), making it unlikely that the vitreous would draw only the hemiretina with severe GCL loss. In view of the importance of M&#x000FC;ller cells for the maintenance of the retinal framework, we believe that RGC atrophy may have a tractional effect on M&#x000FC;ller cells, resulting in increased thickness in areas with RGC damage. Van Buren (<xref ref-type="bibr" rid="B63">63</xref>) found histological evidence of retrograde trans-synaptic degeneration in the INL of primates and humans after optic nerve damage, with cavitary degeneration in the inner half of INL, suggesting damage of the amacrine and M&#x000FC;ller cells. However, according to Gills and Wadsworth (<xref ref-type="bibr" rid="B64">64</xref>), this pattern of degeneration was more likely caused by bipolar cell loss since the amount of cell loss was incompatible to amacrine or M&#x000FC;ller cell damage alone. These findings from the 1960s resemble the microcystic abnormalities observed on OCT today (<xref ref-type="bibr" rid="B22">22</xref>). The present findings of INL enlargement on OCT and reduced OP on mfERG support the hypothesis that optic pathway damage leads to abnormalities in the RGC and possibly also in the retinal cells of the INL. In fact, our study points to a combination of mechanical stretching of the retinal structures and secondary degeneration of the bipolar, amacrine, and M&#x000FC;ller cells in the INL.</p>
<p>To investigate other potential secondary abnormalities in the retina, we evaluated the outer retinal structures by analyzing segmented OCT-measured outer retinal layers and mfERG data. An isolated reduction in N1 amplitude was found in the macular IN quadrant, and PRL thickness was greater in the SN and IN quadrants. However, the P1 amplitude did not differ significantly between BA and normal subjects regardless of the quadrant. To date, no study has investigated the presence of outer retinal abnormalities in BA patients, but evidence of photoreceptor damage in glaucoma and other optic neuropathies by authors using adaptive optics have been reported, with good correlation between areas of ganglion cell loss and lower cone density (<xref ref-type="bibr" rid="B65">65</xref>). Ultrahigh-resolution OCT (<xref ref-type="bibr" rid="B66">66</xref>) and multiphoton imaging of stained tissue (<xref ref-type="bibr" rid="B67">67</xref>) have also revealed PRL abnormalities in glaucoma patients. Despite the differences between conventional ERG and mfERG, the mfERG N1 wave response is thought to correspond to a multifocal form of the full-field ERG a-wave component, indicating photoreceptor activity in the outer retina (<xref ref-type="bibr" rid="B68">68</xref>). Recent OCT studies have described changes in outer retinal structures following optic neuritis, with thickening of the outer retinal layers, especially in severe cases (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Nonetheless, no previous study has evaluated the outer retina in other optic neuropathies, and the actual mechanism responsible for these abnormalities remains unclear.</p>
<p>In the current study, the PRL thickness increased only in the nasal hemiretina of BA patients, along with an isolated N1 amplitude reduction in the IN quadrant, suggesting some mechanical stretching of the outer retinal layers, with some cell injury. Since the only abnormality of mfERG was the reduction of N1 amplitude in the IN retinal quadrant, it is not possible to affirm that there is also trans-synaptic degeneration of the photoreceptors in our set of patients. On the other hand, since the IN retinal quadrant is the most extensively damaged sector in patients with chiasmal compression (which tends to affect the ST VF quadrant), it is possible to infer from the abnormal N1 amplitude observed in the corresponding IN quadrant that secondary photoreceptor degeneration does in fact occur but only when a certain level of retinal damage is reached, therefore affecting only the most heavily damaged retinal quadrant. Further studies are necessary to better understand these findings.</p>
<p>We also evaluated the association between OCT/mfERG measurements and VF data in our patients with chiasmal compression, using the 10-2 SAP testing strategy. Previous studies evaluating structure-function relationships in such patients have used OCT measurements plotted against data obtained with the 24-2 strategy or the 30-2 strategy (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>). Although these strategies may seem adequate for investigating structure-function relationships with OCT-derived peripapillary RNFL thickness measurements, they provide little information to correlate with macular thickness measurements, which are usually based on a 6&#x02009;mm&#x02009;&#x000D7;&#x02009;6&#x02009;mm central area around the fovea. On the other hand, the 10-2 testing strategy evaluates 68 test points in the central 10&#x000B0; providing much more information within the macular area (<xref ref-type="bibr" rid="B61">61</xref>). While significant attention has been given to central VF testing in glaucoma (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>), no previous study has assessed the correlation between 10-2 SAP testing and SD-OCT or ERG data in chiasmal compressive lesions. In the current study, the correlation between changes in OCT-measured thickness and 10-2 SAP sensitivity was positive for the inner layers with reduced thickness and negative for layers with increased thickness (INL and PRL). The strongest correlation was between SAP and GCL, matching data from previous 24-2 VF studies (<xref ref-type="bibr" rid="B22">22</xref>). The coefficients were slightly greater in the present study (up to 0.83 for the best-performing measurements) than in our previous study, using the 24-2 test in a similar set of patients (<xref ref-type="bibr" rid="B22">22</xref>), suggesting that more central VF data would be useful in the evaluation of patients with chiasmal compression, but the difference was not large enough to allow for inferences. However, it is important to stress that our study was conducted on patients with permanent temporal hemianopia secondary to chiasmal compression selected based on the presence of abnormalities on 24-2 VF testing. Thus, it would be interesting to compare the 10-2 and the 24-2 testing strategy with regard to early detection in patients with suspected chiasmal compression. As for OCT and mfERG, significant correlations were found between mfOPs and OCT-measured RNFL, RGC, and INL thickness in the nasal hemiretina. No significant correlation was found between OCT and regular mfERG-measured N1 and P1 amplitudes except for a correlation with ONL thickness in the temporal retinal quadrants (Table <xref ref-type="table" rid="T4">4</xref>). We believe that the abnormalities in the outer retinal layers were too subtle to yield a clinically significant correlation.</p>
<p>In conclusion, our study shows that axonal damage from BA of the optic disk leads to significant thinning of the RNFL, GCL, IPL, and thickening of the INL, OPL, and PRL in relation to healthy eyes, and such eyes can be distinguished from normal eyes by quadrantic analysis of the retinal layers. We also observed changes in OP and mfERG values in the nasal macula of patients with chiasmal compression, indicating functional injury to both the inner and the outer retina. Our results point to the combination of a trans-synaptic mechanism of degeneration and mechanical stretching throughout the retina, but the current data are insufficient to confirm this conclusion, and further studies are necessary to verify it.</p>
</sec>
<sec id="S5" sec-type="author-contributor">
<title>Author Contributions</title>
<p>RA: conception, design, collection of data, analyses of data, writing of the manuscript, and revising the manuscript. MO: conception, design, collection of data, analyses of data, and revising the manuscript. LZ: providing equipment for the study, conception of the study, and revising the manuscript. LC: conception, design, and revising the manuscript. RP: conception, writing the manuscript, and revising the manuscript. MM: providing equipment for the study, conception, design, collection of data, analyses of data, writing of the manuscript, and revising the manuscript.</p>
</sec>
<sec id="S6">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>This study was supported by grants from Funda&#x000E7;&#x000E3;o de Amparo &#x000E0; Pesquisa do Estado de S&#x000E3;o Paulo (FAPESP, Grant No 2013/26585-5), CAPES&#x02014;Coordena&#x000E7;&#x000E3;o de Aperfei&#x000E7;oamento de N&#x000ED;vel Superior, Bras&#x000ED;lia, Brazil, and CNPq&#x02014;Conselho Nacional de Desenvolvimento Cient&#x000ED;fico e Tecnol&#x000F3;gico (No 307393/2014-3), Bras&#x000ED;lia, Brazil. The funding organizations had no role in the design or conduct of this research.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname> <given-names>DC</given-names></name> <name><surname>Raza</surname> <given-names>AS</given-names></name></person-group>. <article-title>On improving the use of OCT imaging for detecting glaucomatous damage</article-title>. <source>Br J Ophthalmol</source> (<year>2014</year>) <volume>98</volume>(<issue>Suppl 2</issue>):<fpage>ii1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/bjophthalmol-2014-305156</pub-id><pub-id pub-id-type="pmid">24934219</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>O</given-names></name> <name><surname>Chopra</surname> <given-names>V</given-names></name> <name><surname>Lu</surname> <given-names>AT</given-names></name> <name><surname>Schuman</surname> <given-names>JS</given-names></name> <name><surname>Ishikawa</surname> <given-names>H</given-names></name> <name><surname>Wollstein</surname> <given-names>G</given-names></name> <etal/></person-group> <article-title>Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography</article-title>. <source>Ophthalmology</source> (<year>2009</year>) <volume>116</volume>:<fpage>.e1</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="doi">10.1016/j.ophtha.2009.05.025</pub-id><pub-id pub-id-type="pmid">19744726</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname> <given-names>DC</given-names></name> <name><surname>Kardon</surname> <given-names>RH</given-names></name></person-group>. <article-title>A framework for comparing structural and functional measures of glaucomatous damage</article-title>. <source>Prog Retin Eye Res</source> (<year>2007</year>) <volume>26</volume>:<fpage>688</fpage>&#x02013;<lpage>710</lpage>.<pub-id pub-id-type="doi">10.1016/j.preteyeres.2007.08.001</pub-id><pub-id pub-id-type="pmid">17889587</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname> <given-names>MLR</given-names></name> <name><surname>Fernandes</surname> <given-names>DB</given-names></name> <name><surname>Ap&#x000F3;stolos-Pereira</surname> <given-names>SL</given-names></name> <name><surname>Callegaro</surname> <given-names>D</given-names></name></person-group>. <article-title>Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2012</year>) <volume>53</volume>:<fpage>3959</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.11-9324</pub-id><pub-id pub-id-type="pmid">22589446</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ratchford</surname> <given-names>JN</given-names></name> <name><surname>Quigg</surname> <given-names>ME</given-names></name> <name><surname>Conger</surname> <given-names>A</given-names></name> <name><surname>Frohman</surname> <given-names>T</given-names></name> <name><surname>Frohman</surname> <given-names>E</given-names></name> <name><surname>Balcer</surname> <given-names>LJ</given-names></name> <etal/></person-group> <article-title>Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies</article-title>. <source>Neurology</source> (<year>2009</year>) <volume>73</volume>:<fpage>302</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181af78b8</pub-id><pub-id pub-id-type="pmid">19636050</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naismith</surname> <given-names>RT</given-names></name> <name><surname>Tutlam</surname> <given-names>NT</given-names></name> <name><surname>Xu</surname> <given-names>J</given-names></name> <name><surname>Klawiter</surname> <given-names>EC</given-names></name> <name><surname>Shepherd</surname> <given-names>J</given-names></name> <name><surname>Trinkaus</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis</article-title>. <source>Neurology</source> (<year>2009</year>) <volume>72</volume>:<fpage>1077</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1212/01.wnl.0000345042.53843.d5</pub-id><pub-id pub-id-type="pmid">19307541</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname> <given-names>MLR</given-names></name> <name><surname>Cunha</surname> <given-names>LP</given-names></name> <name><surname>Costa-Cunha</surname> <given-names>LVF</given-names></name> <name><surname>Maia</surname> <given-names>OO</given-names></name> <name><surname>Oyamada</surname> <given-names>MK</given-names></name></person-group>. <article-title>Relationship between optical coherence tomography, pattern electroretinogram and automated perimetry in eyes with temporal hemianopia from chiasmal compression</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2009</year>) <volume>50</volume>:<fpage>3535</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.08-3093</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname> <given-names>ML</given-names></name> <name><surname>Leal</surname> <given-names>BC</given-names></name> <name><surname>Rosa</surname> <given-names>AA</given-names></name> <name><surname>Bronstein</surname> <given-names>MD</given-names></name></person-group>. <article-title>Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve</article-title>. <source>Br J Ophthalmol</source> (<year>2004</year>) <volume>88</volume>:<fpage>896</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/bjo.2003.038489</pub-id><pub-id pub-id-type="pmid">15205233</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barboni</surname> <given-names>P</given-names></name> <name><surname>Savini</surname> <given-names>G</given-names></name> <name><surname>Feuer</surname> <given-names>WJ</given-names></name> <name><surname>Budenz</surname> <given-names>DL</given-names></name> <name><surname>Carbonelli</surname> <given-names>M</given-names></name> <name><surname>Chicani</surname> <given-names>F</given-names></name> <etal/></person-group> <article-title>Retinal nerve fiber layer thickness variability in Leber hereditary optic neuropathy carriers</article-title>. <source>Eur J Ophthalmol</source> (<year>2012</year>) <volume>22</volume>:<fpage>985</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.5301/ejo.5000154</pub-id><pub-id pub-id-type="pmid">22562299</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barboni</surname> <given-names>P</given-names></name> <name><surname>Savini</surname> <given-names>G</given-names></name> <name><surname>Parisi</surname> <given-names>V</given-names></name> <name><surname>Carbonelli</surname> <given-names>M</given-names></name> <name><surname>La Morgia</surname> <given-names>C</given-names></name> <name><surname>Maresca</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age</article-title>. <source>Ophthalmology</source> (<year>2011</year>) <volume>118</volume>:<fpage>2076</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.ophtha.2011.02.027</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akashi</surname> <given-names>A</given-names></name> <name><surname>Kanamori</surname> <given-names>A</given-names></name> <name><surname>Ueda</surname> <given-names>K</given-names></name> <name><surname>Matsumoto</surname> <given-names>Y</given-names></name> <name><surname>Yamada</surname> <given-names>Y</given-names></name> <name><surname>Nakamura</surname> <given-names>M</given-names></name></person-group>. <article-title>The detection of macular analysis by SD-OCT for optic chiasmal compression neuropathy and nasotemporal overlap</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2014</year>) <volume>55</volume>:<fpage>4667</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.14-14766</pub-id><pub-id pub-id-type="pmid">25015351</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danesh-Meyer</surname> <given-names>HV</given-names></name> <name><surname>Papchenko</surname> <given-names>T</given-names></name> <name><surname>Savino</surname> <given-names>PJ</given-names></name> <name><surname>Law</surname> <given-names>A</given-names></name> <name><surname>Evans</surname> <given-names>J</given-names></name> <name><surname>Gamble</surname> <given-names>GD</given-names></name></person-group>. <article-title>In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2008</year>) <volume>49</volume>:<fpage>1879</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.07-1127</pub-id><pub-id pub-id-type="pmid">18263812</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname> <given-names>MLR</given-names></name> <name><surname>Costa-Cunha</surname> <given-names>LVF</given-names></name> <name><surname>Cunha</surname> <given-names>LP</given-names></name> <name><surname>Malta</surname> <given-names>RFS</given-names></name></person-group>. <article-title>Correlation between macular and retinal nerve fibre layer Fourier-domain OCT measurements and visual field loss in chiasmal compression</article-title>. <source>Eye</source> (<year>2010</year>) <volume>24</volume>:<fpage>1382</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1038/eye.2010.48</pub-id><pub-id pub-id-type="pmid">20431609</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abegg</surname> <given-names>M</given-names></name> <name><surname>Zinkernagel</surname> <given-names>M</given-names></name> <name><surname>Wolf</surname> <given-names>S</given-names></name></person-group>. <article-title>Microcystic macular degeneration from optic neuropathy</article-title>. <source>Brain</source> (<year>2012</year>) <volume>135</volume>:<fpage>e225</fpage>.<pub-id pub-id-type="doi">10.1093/brain/aws215</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gelfand</surname> <given-names>JM</given-names></name> <name><surname>Nolan</surname> <given-names>R</given-names></name> <name><surname>Schwartz</surname> <given-names>DM</given-names></name> <name><surname>Graves</surname> <given-names>J</given-names></name> <name><surname>Green</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Microcystic macular oedema in multiple sclerosis is associated with disease severity</article-title>. <source>Brain</source> (<year>2012</year>) <volume>135</volume>:<fpage>1786</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1093/brain/aws098</pub-id><pub-id pub-id-type="pmid">22539259</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gelfand</surname> <given-names>JM</given-names></name> <name><surname>Cree</surname> <given-names>BA</given-names></name> <name><surname>Nolan</surname> <given-names>R</given-names></name> <name><surname>Arnow</surname> <given-names>S</given-names></name> <name><surname>Green</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Microcystic inner nuclear layer abnormalities and neuromyelitis optica</article-title>. <source>JAMA Neurol</source> (<year>2013</year>) <volume>70</volume>(<issue>5</issue>):<fpage>629</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1001/jamaneurol.2013.1832</pub-id><pub-id pub-id-type="pmid">23529376</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname> <given-names>DB</given-names></name> <name><surname>Raza</surname> <given-names>AS</given-names></name> <name><surname>Nogueira</surname> <given-names>RG</given-names></name> <name><surname>Wang</surname> <given-names>D</given-names></name> <name><surname>Callegaro</surname> <given-names>D</given-names></name> <name><surname>Hood</surname> <given-names>DC</given-names></name> <etal/></person-group> <article-title>Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography</article-title>. <source>Ophthalmology</source> (<year>2013</year>) <volume>120</volume>:<fpage>387</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.ophtha.2012.07.066</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sotirchos</surname> <given-names>ES</given-names></name> <name><surname>Saidha</surname> <given-names>S</given-names></name> <name><surname>Byraiah</surname> <given-names>G</given-names></name> <name><surname>Mealy</surname> <given-names>MA</given-names></name> <name><surname>Ibrahim</surname> <given-names>MA</given-names></name> <name><surname>Sepah</surname> <given-names>YJ</given-names></name> <etal/></person-group> <article-title>In vivo identification of morphologic retinal abnormalities in neuromyelitis optica</article-title>. <source>Neurology</source> (<year>2013</year>) <volume>80</volume>:<fpage>1406</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1212/WNL.0b013e31828c2f7a</pub-id><pub-id pub-id-type="pmid">23516321</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burggraaff</surname> <given-names>MC</given-names></name> <name><surname>Trieu</surname> <given-names>J</given-names></name> <name><surname>de Vries-Knoppert</surname> <given-names>WA</given-names></name> <name><surname>Balk</surname> <given-names>L</given-names></name> <name><surname>Petzold</surname> <given-names>A</given-names></name></person-group>. <article-title>The clinical spectrum of microcystic macular edema</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2014</year>) <volume>55</volume>:<fpage>952</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.13-12912</pub-id><pub-id pub-id-type="pmid">24398089</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barboni</surname> <given-names>P</given-names></name> <name><surname>Carelli</surname> <given-names>V</given-names></name> <name><surname>Savini</surname> <given-names>G</given-names></name> <name><surname>Carbonelli</surname> <given-names>M</given-names></name> <name><surname>La Morgia</surname> <given-names>C</given-names></name> <name><surname>Sadun</surname> <given-names>AA</given-names></name></person-group>. <article-title>Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration</article-title>. <source>Brain</source> (<year>2013</year>) <volume>136</volume>(<issue>Pt 7</issue>):<fpage>e239</fpage>.<pub-id pub-id-type="doi">10.1093/brain/awt014</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balk</surname> <given-names>LJ</given-names></name> <name><surname>Killestein</surname> <given-names>J</given-names></name> <name><surname>Polman</surname> <given-names>CH</given-names></name> <name><surname>Uitdehaag</surname> <given-names>BM</given-names></name> <name><surname>Petzold</surname> <given-names>A</given-names></name></person-group>. <article-title>Microcystic macular oedema confirmed, but not specific for multiple sclerosis</article-title>. <source>Brain</source> (<year>2012</year>) <volume>135</volume>:<fpage>e226</fpage>.<pub-id pub-id-type="doi">10.1093/brain/aws216</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname> <given-names>MLR</given-names></name> <name><surname>Hokazono</surname> <given-names>K</given-names></name> <name><surname>Fernandes</surname> <given-names>DB</given-names></name> <name><surname>Costa-Cunha</surname> <given-names>LVF</given-names></name> <name><surname>Sousa</surname> <given-names>RM</given-names></name> <name><surname>Raza</surname> <given-names>AS</given-names></name> <etal/></person-group> <article-title>Evaluation of inner retinal layers in eyes with temporal hemianopic visual loss from chiasmal compression using optical coherence tomography</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2014</year>) <volume>55</volume>:<fpage>3328</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.14-14118</pub-id><pub-id pub-id-type="pmid">24764062</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname> <given-names>ML</given-names></name> <name><surname>Ara&#x000FA;jo</surname> <given-names>RB</given-names></name> <name><surname>Suzuki</surname> <given-names>AC</given-names></name> <name><surname>Cunha</surname> <given-names>LP</given-names></name> <name><surname>Preti</surname> <given-names>RC</given-names></name></person-group>. <article-title>Homonymous hemianopic hyporeflective retinal abnormality on infrared confocal scanning laser photography: a novel sign of optic tract lesion</article-title>. <source>J Neuroophthalmol</source> (<year>2016</year>) <volume>36</volume>:<fpage>46</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1097/WNO.0000000000000278</pub-id><pub-id pub-id-type="pmid">26172159</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bearse</surname> <given-names>MA</given-names></name> <name><surname>Han</surname> <given-names>Y</given-names></name> <name><surname>Schneck</surname> <given-names>ME</given-names></name> <name><surname>Adams</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Retinal function in normal and diabetic eyes mapped with the slow flash multifocal electroretinogram</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2004</year>) <volume>45</volume>:<fpage>296</fpage>&#x02013;<lpage>304</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.03-0424</pub-id><pub-id pub-id-type="pmid">14691187</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bearse</surname> <given-names>MA</given-names> <suffix>Jr</suffix></name> <name><surname>Shimada</surname> <given-names>Y</given-names></name> <name><surname>Sutter</surname> <given-names>EE</given-names></name></person-group>. <article-title>Distribution of oscillatory components in the central retina</article-title>. <source>Doc Ophthalmol</source> (<year>2000</year>) <volume>100</volume>:<fpage>185</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="doi">10.1023/A:1002783719958</pub-id><pub-id pub-id-type="pmid">11142746</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heynen</surname> <given-names>H</given-names></name> <name><surname>Wachtmeister</surname> <given-names>L</given-names></name> <name><surname>van Norren</surname> <given-names>D</given-names></name></person-group>. <article-title>Origin of the oscillatory potentials in the primate retina</article-title>. <source>Vision Res</source> (<year>1985</year>) <volume>25</volume>:<fpage>1365</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1016/0042-6989(85)90214-7</pub-id><pub-id pub-id-type="pmid">4090272</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wachtmeister</surname> <given-names>L</given-names></name> <name><surname>Dowling</surname> <given-names>JE</given-names></name></person-group>. <article-title>The oscillatory potentials of the mudpuppy retina</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>1978</year>) <volume>17</volume>:<fpage>1176</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">721390</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wachtmeister</surname> <given-names>L</given-names></name></person-group>. <article-title>Oscillatory potentials in the retina: what do they reveal</article-title>. <source>Prog Retin Eye Res</source> (<year>1998</year>) <volume>17</volume>:<fpage>485</fpage>&#x02013;<lpage>521</lpage>.<pub-id pub-id-type="doi">10.1016/S1350-9462(98)00006-8</pub-id><pub-id pub-id-type="pmid">9777648</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wachtmeister</surname> <given-names>L</given-names></name></person-group>. <article-title>Some aspects of the oscillatory response of the retina</article-title>. <source>Prog Brain Res</source> (<year>2001</year>) <volume>131</volume>:<fpage>465</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1016/S0079-6123(01)31037-3</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurtenbach</surname> <given-names>A</given-names></name> <name><surname>Weiss</surname> <given-names>M</given-names></name></person-group>. <article-title>Effect of aging on multifocal oscillatory potentials</article-title>. <source>J Opt Soc Am A Opt Image Sci Vis</source> (<year>2002</year>) <volume>19</volume>:<fpage>190</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1364/JOSAA.19.000190</pub-id><pub-id pub-id-type="pmid">11778724</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>S</given-names></name> <name><surname>Sutter</surname> <given-names>EE</given-names></name></person-group>. <article-title>A topographic study of oscillatory potentials in man</article-title>. <source>Vis Neurosci</source> (<year>1995</year>) <volume>12</volume>:<fpage>1013</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1017/S0952523800006696</pub-id><pub-id pub-id-type="pmid">8962824</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JC</given-names></name> <name><surname>Brown</surname> <given-names>B</given-names></name> <name><surname>Schmid</surname> <given-names>KL</given-names></name></person-group>. <article-title>Slow flash multifocal electroretinogram in myopia</article-title>. <source>Vision Res</source> (<year>2006</year>) <volume>46</volume>:<fpage>2869</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1016/j.visres.2006.02.021</pub-id><pub-id pub-id-type="pmid">16647738</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname> <given-names>K</given-names></name> <name><surname>Yamamoto</surname> <given-names>S</given-names></name> <name><surname>Mitamura</surname> <given-names>Y</given-names></name> <name><surname>Sugawara</surname> <given-names>T</given-names></name> <name><surname>Mizunoya</surname> <given-names>S</given-names></name></person-group>. <article-title>Changes in multifocal oscillatory potentials after internal limiting membrane removal for macular hole</article-title>. <source>Doc Ophthalmol</source> (<year>2007</year>) <volume>114</volume>:<fpage>75</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1007/s10633-006-9042-9</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>JYC</given-names></name> <name><surname>Luu</surname> <given-names>CD</given-names></name> <name><surname>Yeo</surname> <given-names>IYS</given-names></name> <name><surname>Chee</surname> <given-names>SP</given-names></name></person-group>. <article-title>The outer and inner retinal function in patients with multiple evanescent white dot syndrome</article-title>. <source>Clin Exp Ophthalmol</source> (<year>2009</year>) <volume>37</volume>:<fpage>478</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1111/j.1442-9071.2009.02062.x</pub-id><pub-id pub-id-type="pmid">19624344</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Onozu</surname> <given-names>H</given-names></name> <name><surname>Yamamoto</surname> <given-names>S</given-names></name></person-group>. <article-title>Oscillatory potentials of multifocal electroretinogram in diabetic retinopathy</article-title>. <source>Doc Ophthalmol</source> (<year>2003</year>) <volume>106</volume>:<fpage>327</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1023/A:1022903627332</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bearse</surname> <given-names>MA</given-names></name> <name><surname>Han</surname> <given-names>Y</given-names></name> <name><surname>Schneck</surname> <given-names>ME</given-names></name> <name><surname>Barez</surname> <given-names>S</given-names></name> <name><surname>Jacobsen</surname> <given-names>C</given-names></name> <name><surname>Adams</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2004</year>) <volume>45</volume>:<fpage>3259</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.04-0308</pub-id><pub-id pub-id-type="pmid">15326149</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palmowski-Wolfe</surname> <given-names>AM</given-names></name> <name><surname>Allgayer</surname> <given-names>RJ</given-names></name> <name><surname>Vernaleken</surname> <given-names>B</given-names></name> <name><surname>Sch&#x000F6;tzau</surname> <given-names>A</given-names></name> <name><surname>Ruprecht</surname> <given-names>KW</given-names></name></person-group>. <article-title>Slow-stimulated multifocal ERG in high- and normal-tension glaucoma</article-title>. <source>Doc Ophthalmol</source> (<year>2006</year>) <volume>112</volume>:<fpage>157</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1007/s10633-006-0007-9</pub-id><pub-id pub-id-type="pmid">16786253</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname> <given-names>S</given-names></name> <name><surname>Jonas</surname> <given-names>JB</given-names></name></person-group>. <article-title>Decreased photoreceptor count in human eyes with secondary angle-closure glaucoma</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>1992</year>) <volume>33</volume>:<fpage>2532</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">1634350</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de</surname> <given-names>CC</given-names></name></person-group>. <article-title>Histopathology of retina and optic nerve with experimental glaucoma</article-title>. <source>Arch Ophthalmol</source> (<year>1962</year>) <volume>67</volume>:<fpage>483</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1001/archopht.1962.00960020483017</pub-id></citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaegan</surname></name> <name><surname>Graham</surname> <given-names>SL</given-names></name> <name><surname>Goldberg</surname> <given-names>I</given-names></name> <name><surname>Buckland</surname> <given-names>L</given-names></name> <name><surname>Hollows</surname> <given-names>FC</given-names></name></person-group>. <article-title>Flash and pattern electroretinogram changes with optic atrophy and glaucoma</article-title>. <source>Exp Eye Res</source> (<year>1995</year>) <volume>60</volume>:<fpage>697</fpage>&#x02013;<lpage>706</lpage>.<pub-id pub-id-type="doi">10.1016/S0014-4835(05)80011-9</pub-id><pub-id pub-id-type="pmid">7641852</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname> <given-names>CK</given-names></name> <name><surname>Ye</surname> <given-names>C</given-names></name> <name><surname>Weinreb</surname> <given-names>RN</given-names></name> <name><surname>Yu</surname> <given-names>M</given-names></name> <name><surname>Lai</surname> <given-names>G</given-names></name> <name><surname>Lam</surname> <given-names>DS</given-names></name></person-group>. <article-title>Impact of age-related change of retinal nerve fiber layer and macular thicknesses on evaluation of glaucoma progression</article-title>. <source>Ophthalmology</source> (<year>2013</year>) <volume>120</volume>:<fpage>2485</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/j.ophtha.2013.07.021</pub-id><pub-id pub-id-type="pmid">23993360</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kendell</surname> <given-names>KR</given-names></name> <name><surname>Quigley</surname> <given-names>HA</given-names></name> <name><surname>Kerrigan</surname> <given-names>LA</given-names></name> <name><surname>Pease</surname> <given-names>ME</given-names></name> <name><surname>Quigley</surname> <given-names>EN</given-names></name></person-group>. <article-title>Primary open-angle glaucoma is not associated with photoreceptor loss</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>1995</year>) <volume>36</volume>:<fpage>200</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">7822147</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saidha</surname> <given-names>S</given-names></name> <name><surname>Syc</surname> <given-names>SB</given-names></name> <name><surname>Ibrahim</surname> <given-names>MA</given-names></name> <name><surname>Eckstein</surname> <given-names>C</given-names></name> <name><surname>Warner</surname> <given-names>CV</given-names></name> <name><surname>Farrell</surname> <given-names>SK</given-names></name> <etal/></person-group> <article-title>Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography</article-title>. <source>Brain</source> (<year>2011</year>) <volume>134</volume>:<fpage>518</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1093/brain/awq346</pub-id><pub-id pub-id-type="pmid">21252110</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Al-Louzi</surname> <given-names>OA</given-names></name> <name><surname>Bhargava</surname> <given-names>P</given-names></name> <name><surname>Newsome</surname> <given-names>SD</given-names></name> <name><surname>Balcer</surname> <given-names>LJ</given-names></name> <name><surname>Frohman</surname> <given-names>EM</given-names></name> <name><surname>Crainiceanu</surname> <given-names>C</given-names></name> <etal/></person-group> <article-title>Outer retinal changes following acute optic neuritis</article-title>. <source>Mult Scler</source> (<year>2016</year>) <volume>22</volume>:<fpage>362</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1177/1352458515590646</pub-id><pub-id pub-id-type="pmid">26209589</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Behbehani</surname> <given-names>R</given-names></name> <name><surname>Abu Al-Hassan</surname> <given-names>A</given-names></name> <name><surname>Al-Salahat</surname> <given-names>A</given-names></name> <name><surname>Sriraman</surname> <given-names>D</given-names></name> <name><surname>Oakley</surname> <given-names>JD</given-names></name> <name><surname>Alroughani</surname> <given-names>R</given-names></name></person-group>. <article-title>Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis</article-title>. <source>PLoS One</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0172120</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0172120</pub-id><pub-id pub-id-type="pmid">28192539</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mikelberg</surname> <given-names>FS</given-names></name> <name><surname>Yidegiligne</surname> <given-names>HM</given-names></name></person-group>. <article-title>Axonal loss in band atrophy of the optic-nerve in craniopharyngioma &#x02013; a quantitative-analysis</article-title>. <source>Can J Ophthalmol</source> (<year>1993</year>) <volume>28</volume>:<fpage>69</fpage>&#x02013;<lpage>71</lpage>.</citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uns&#x000F6;ld</surname> <given-names>R</given-names></name> <name><surname>Hoyt</surname> <given-names>WF</given-names></name></person-group>. <article-title>Band atrophy of the optic nerve. The histology of temporal hemianopsia</article-title>. <source>Arch Ophthalmol</source> (<year>1980</year>) <volume>98</volume>:<fpage>1637</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1001/archopht.1980.01020040489020</pub-id><pub-id pub-id-type="pmid">7425927</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname> <given-names>MLR</given-names></name> <name><surname>Medeiros</surname> <given-names>FA</given-names></name> <name><surname>Ostroscki</surname> <given-names>MR</given-names></name></person-group>. <article-title>Quantitative analysis of axonal loss in band atrophy of the optic nerve using scanning laser polarimetry</article-title>. <source>Br J Ophthalmol</source> (<year>2003</year>) <volume>87</volume>:<fpage>32</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1136/bjo.87.1.32</pub-id><pub-id pub-id-type="pmid">12488259</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname> <given-names>LP</given-names></name> <name><surname>Oyamada</surname> <given-names>MK</given-names></name> <name><surname>Monteiro</surname> <given-names>MLR</given-names></name></person-group>. <article-title>Pattern electroretinograms for the detection of neural loss in patients with permanent temporal visual field defect from chiasmal compression</article-title>. <source>Doc Ophthalmol</source> (<year>2008</year>) <volume>117</volume>:<fpage>223</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1007/s10633-008-9126-9</pub-id><pub-id pub-id-type="pmid">18401605</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leite</surname> <given-names>MT</given-names></name> <name><surname>Rao</surname> <given-names>HL</given-names></name> <name><surname>Zangwill</surname> <given-names>LM</given-names></name> <name><surname>Weinreb</surname> <given-names>RN</given-names></name> <name><surname>Medeiros</surname> <given-names>FA</given-names></name></person-group>. <article-title>Comparison of the diagnostic accuracies of the Spectralis, Cirrus, and RTVue optical coherence tomography devices in glaucoma</article-title>. <source>Ophthalmology</source> (<year>2011</year>) <volume>118</volume>:<fpage>1334</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.ophtha.2010.11.029</pub-id><pub-id pub-id-type="pmid">21377735</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trimboli-Heidler</surname> <given-names>C</given-names></name> <name><surname>Vogt</surname> <given-names>K</given-names></name> <name><surname>Avery</surname> <given-names>RA</given-names></name></person-group>. <article-title>Volume averaging of spectral-domain optical coherence tomography impacts retinal segmentation in children</article-title>. <source>Transl Vis Sci Technol</source> (<year>2016</year>) <volume>5</volume>:<fpage>12</fpage>.<pub-id pub-id-type="doi">10.1167/tvst.5.4.12</pub-id><pub-id pub-id-type="pmid">27570711</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Herranz</surname> <given-names>A</given-names></name> <name><surname>Balk</surname> <given-names>LJ</given-names></name> <name><surname>Oberwahrenbrock</surname> <given-names>T</given-names></name> <name><surname>Saidha</surname> <given-names>S</given-names></name> <name><surname>Martinez-Lapiscina</surname> <given-names>EH</given-names></name> <name><surname>Lagreze</surname> <given-names>WA</given-names></name> <etal/></person-group> <article-title>The APOSTEL recommendations for reporting quantitative optical coherence tomography studies</article-title>. <source>Neurology</source> (<year>2016</year>) <volume>86</volume>:<fpage>2303</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1212/WNL.0000000000002774</pub-id><pub-id pub-id-type="pmid">27225223</pub-id></citation></ref>
<ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname> <given-names>DC</given-names></name> <name><surname>Bach</surname> <given-names>M</given-names></name> <name><surname>Brigell</surname> <given-names>M</given-names></name> <name><surname>Keating</surname> <given-names>D</given-names></name> <name><surname>Kondo</surname> <given-names>M</given-names></name> <name><surname>Lyons</surname> <given-names>JS</given-names></name> <etal/></person-group> <article-title>ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition)</article-title>. <source>Doc Ophthalmol</source> (<year>2012</year>) <volume>124</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1007/s10633-011-9296-8.ISCEV</pub-id><pub-id pub-id-type="pmid">22038576</pub-id></citation></ref>
<ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marmor</surname> <given-names>MF</given-names></name> <name><surname>Holder</surname> <given-names>GE</given-names></name> <name><surname>Seeliger</surname> <given-names>MW</given-names></name> <name><surname>Yamamoto</surname> <given-names>S</given-names></name> <collab>International Society for Clinical Electrophysiology of Vision</collab></person-group>. <article-title>Standard for clinical electroretinography (2004 update)</article-title>. <source>Doc Ophthalmol</source> (<year>2004</year>) <volume>108</volume>:<fpage>107</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1023/B:DOOP.0000036793.44912.45</pub-id></citation></ref>
<ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moura</surname> <given-names>FC</given-names></name> <name><surname>Medeiros</surname> <given-names>FA</given-names></name> <name><surname>Monteiro</surname> <given-names>MLR</given-names></name></person-group>. <article-title>Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography</article-title>. <source>Ophthalmology</source> (<year>2007</year>) <volume>114</volume>:<fpage>175</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.ophtha.2006.06.045</pub-id><pub-id pub-id-type="pmid">17070583</pub-id></citation></ref>
<ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JC</given-names></name> <name><surname>Brown</surname> <given-names>B</given-names></name> <name><surname>Schmid</surname> <given-names>KL</given-names></name></person-group>. <article-title>Evaluation of inner retinal function in myopia using oscillatory potentials of the multifocal electroretinogram</article-title>. <source>Vision Res</source> (<year>2006</year>) <volume>46</volume>:<fpage>4096</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1016/j.visres.2006.07.033</pub-id><pub-id pub-id-type="pmid">17010409</pub-id></citation></ref>
<ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>W</given-names></name> <name><surname>Wright</surname> <given-names>T</given-names></name> <name><surname>Dupuis</surname> <given-names>A</given-names></name> <name><surname>Lakhani</surname> <given-names>E</given-names></name> <name><surname>Westall</surname> <given-names>CA</given-names></name></person-group>. <article-title>Localizing functional damage in the neural retina of adolescents and young adults with type 1 diabetes</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2014</year>) <volume>55</volume>:<fpage>2432</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.13-13232</pub-id><pub-id pub-id-type="pmid">24526434</pub-id></citation></ref>
<ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saidha</surname> <given-names>S</given-names></name> <name><surname>Sotirchos</surname> <given-names>ES</given-names></name> <name><surname>Ibrahim</surname> <given-names>MA</given-names></name> <name><surname>Crainiceanu</surname> <given-names>CM</given-names></name> <name><surname>Gelfand</surname> <given-names>JM</given-names></name> <name><surname>Sepah</surname> <given-names>YJ</given-names></name> <etal/></person-group> <article-title>Relationships of the inner nuclear layer of the retina with clinicoradiologic disease characteristics in multiple sclerosis; a retrospective study</article-title>. <source>Lancet Neurol</source> (<year>2012</year>) <volume>11</volume>:<fpage>963</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/S1474-4422(12)70213-2.Relationships</pub-id></citation></ref>
<ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaushik</surname> <given-names>M</given-names></name> <name><surname>Wang</surname> <given-names>CY</given-names></name> <name><surname>Barnett</surname> <given-names>MH</given-names></name> <name><surname>Garrick</surname> <given-names>R</given-names></name> <name><surname>Parratt</surname> <given-names>J</given-names></name> <name><surname>Graham</surname> <given-names>SL</given-names></name> <etal/></person-group> <article-title>Inner nuclear layer thickening is inversely proportional to retinal ganglion cell loss in optic neuritis</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e78341</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0078341</pub-id><pub-id pub-id-type="pmid">24098599</pub-id></citation></ref>
<ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolff</surname> <given-names>B</given-names></name> <name><surname>Basdekidou</surname> <given-names>C</given-names></name> <name><surname>Vasseur</surname> <given-names>V</given-names></name> <name><surname>Mauget-Fa&#x000FF;sse</surname> <given-names>M</given-names></name> <name><surname>Sahel</surname> <given-names>J-A</given-names></name> <name><surname>Vignal</surname> <given-names>C</given-names></name></person-group>. <article-title>Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding</article-title>. <source>Retina</source> (<year>2013</year>) <volume>33</volume>:<fpage>2133</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1097/IAE.0b013e31828e68d0</pub-id><pub-id pub-id-type="pmid">23644558</pub-id></citation></ref>
<ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curcio</surname> <given-names>CA</given-names></name> <name><surname>Allen</surname> <given-names>KA</given-names></name></person-group>. <article-title>Topography of ganglion cells in human retina</article-title>. <source>J Comp Neurol</source> (<year>1990</year>) <volume>300</volume>:<fpage>5</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1002/cne.903000103</pub-id><pub-id pub-id-type="pmid">2229487</pub-id></citation></ref>
<ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carbonelli</surname> <given-names>M</given-names></name> <name><surname>La Morgia</surname> <given-names>C</given-names></name> <name><surname>Savini</surname> <given-names>G</given-names></name> <name><surname>Cascavilla</surname> <given-names>ML</given-names></name> <name><surname>Borrelli</surname> <given-names>E</given-names></name> <name><surname>Chicani</surname> <given-names>F</given-names></name> <etal/></person-group> <article-title>Macular microcysts in mitochondrial optic neuropathies: prevalence and retinal layer thickness measurements</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0127906</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0127906</pub-id><pub-id pub-id-type="pmid">26047507</pub-id></citation></ref>
<ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Buren</surname> <given-names>JM</given-names></name></person-group>. <article-title>Trans-synaptic retrograde degeneration in the visual system of primates</article-title>. <source>J Neurol Neurosurg Psychiatry</source> (<year>1963</year>) <volume>26</volume>:<fpage>402</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/jnnp.26.5.402</pub-id></citation></ref>
<ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gills</surname> <given-names>JP</given-names> <suffix>Jr</suffix></name> <name><surname>Wadsworth</surname> <given-names>JA</given-names></name></person-group>. <article-title>Degeneration of the inner nuclear layer of the retina following lesions of the optic nerve</article-title>. <source>Trans Am Ophthalmol Soc</source> (<year>1966</year>) <volume>64</volume>:<fpage>66</fpage>&#x02013;<lpage>88</lpage>.</citation></ref>
<ref id="B65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname> <given-names>JS</given-names></name> <name><surname>Keltner</surname> <given-names>JL</given-names></name> <name><surname>Zawadzki</surname> <given-names>RJ</given-names></name> <name><surname>Choi</surname> <given-names>SS</given-names></name></person-group>. <article-title>Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies</article-title>. <source>Eye (Lond)</source> (<year>2011</year>) <volume>25</volume>:<fpage>279</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.1038/eye.2010.218</pub-id><pub-id pub-id-type="pmid">21293495</pub-id></citation></ref>
<ref id="B66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>SS</given-names></name> <name><surname>Zawadzki</surname> <given-names>RJ</given-names></name> <name><surname>Lim</surname> <given-names>MC</given-names></name> <name><surname>Brandt</surname> <given-names>JD</given-names></name> <name><surname>Keltner</surname> <given-names>JL</given-names></name> <name><surname>Doble</surname> <given-names>N</given-names></name> <etal/></person-group> <article-title>Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging</article-title>. <source>Br J Ophthalmol</source> (<year>2011</year>) <volume>95</volume>:<fpage>131</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1136/bjo.2010.183756.Evidence</pub-id><pub-id pub-id-type="pmid">20956277</pub-id></citation></ref>
<ref id="B67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname> <given-names>Y</given-names></name> <name><surname>Garrahan</surname> <given-names>N</given-names></name> <name><surname>Hermann</surname> <given-names>B</given-names></name> <name><surname>Becker</surname> <given-names>DL</given-names></name> <name><surname>Hernandez</surname> <given-names>MR</given-names></name> <name><surname>Boulton</surname> <given-names>ME</given-names></name> <etal/></person-group> <article-title>Quantification of retinal transneuronal degeneration in human glaucoma: a novel multiphoton-DAPI approach</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2008</year>) <volume>49</volume>:<fpage>1940</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.07-0735</pub-id><pub-id pub-id-type="pmid">18436826</pub-id></citation></ref>
<ref id="B68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname> <given-names>DC</given-names></name></person-group>. <article-title>Assessing retinal function with the multifocal technique</article-title>. <source>Prog Retin Eye Res</source> (<year>2000</year>) <volume>19</volume>:<fpage>607</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1016/S1350-9462(00)00013-6</pub-id><pub-id pub-id-type="pmid">10925245</pub-id></citation></ref>
<ref id="B69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname> <given-names>M</given-names></name> <name><surname>Ishikawa-Tabuchi</surname> <given-names>K</given-names></name> <name><surname>Kanamori</surname> <given-names>A</given-names></name> <name><surname>Yamada</surname> <given-names>Y</given-names></name> <name><surname>Negi</surname> <given-names>A</given-names></name></person-group>. <article-title>Better performance of RTVue than Cirrus spectral-domain optical coherence tomography in detecting band atrophy of the optic nerve</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source> (<year>2012</year>) <volume>250</volume>:<fpage>1499</fpage>&#x02013;<lpage>507</lpage>.<pub-id pub-id-type="doi">10.1007/s00417-012-2095-4</pub-id><pub-id pub-id-type="pmid">22752123</pub-id></citation></ref>
<ref id="B70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danesh-Meyer</surname> <given-names>HV</given-names></name> <name><surname>Carroll</surname> <given-names>SC</given-names></name> <name><surname>Foroozan</surname> <given-names>R</given-names></name> <name><surname>Savino</surname> <given-names>PJ</given-names></name> <name><surname>Fan</surname> <given-names>J</given-names></name> <name><surname>Jiang</surname> <given-names>Y</given-names></name> <etal/></person-group> <article-title>Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression</article-title>. <source>Invest Ophthalmol Vis Sci</source> (<year>2006</year>) <volume>47</volume>:<fpage>4827</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1167/iovs.06-0327</pub-id><pub-id pub-id-type="pmid">17065494</pub-id></citation></ref>
<ref id="B71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname> <given-names>DC</given-names></name> <name><surname>Raza</surname> <given-names>AS</given-names></name> <name><surname>de Moraes</surname> <given-names>CG</given-names></name> <name><surname>Liebmann</surname> <given-names>JM</given-names></name> <name><surname>Ritch</surname> <given-names>R</given-names></name></person-group>. <article-title>Glaucomatous damage of the macula</article-title>. <source>Prog Retin Eye Res</source> (<year>2013</year>) <volume>32</volume>:<fpage>1</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.preteyeres.2012.08.003</pub-id></citation></ref>
<ref id="B72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan-mee</surname> <given-names>M</given-names></name> <name><surname>Karin Tran</surname> <given-names>MT</given-names></name> <name><surname>Pensyl</surname> <given-names>D</given-names></name> <name><surname>Tsan</surname> <given-names>G</given-names></name> <name><surname>Katiyar</surname> <given-names>S</given-names></name></person-group>. <article-title>Prevalence, features, and severity of glaucomatous visual field loss measured with the 10-2 achromatic threshold visual field test</article-title>. <source>Am J Ophthalmol</source> (<year>2016</year>) <volume>168</volume>:<fpage>40</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/j.ajo.2016.05.003</pub-id><pub-id pub-id-type="pmid">27173372</pub-id></citation></ref>
</ref-list>
</back>
</article>